Complimenti.....Sei entrato nel piu' completo Portale sulle Medicine Alternative, Biologico  Naturali e Spirituali - la Guida alla Salute Naturale - Leggi, Studia, Pratica e starai in Perfetta  Salute, senza Farmaci ne' Vaccini

GUIDA  alla  SALUTE con la Natura

"Medicina Alternativa"   per  CORPO  e   SPIRITO
Alternative Medicine"
  for  BODY  and SPIRIT


- 2  
(Référes - Bibliografie)

Adams CR, Ziegler DK, Lin JT, ‘Mercury intoxication simulating amyotrophic lateral sclerosis’, JAMA 1983; 250:642-643.
Al-Balaghi S, Möller E, Möller G, Abedi-Valugerdi M, ‘Mercury induces polyclonal B cell activation, autoantibody production and renal immune complex deposits in young (NZB x NZW) F1 hybrids’, Eur J Immunol, July 1996, 26(7):1519-1526
Alberti A, Pirrone P, Elia M, Waring RH, Romano C, ‘Sulphation deficit in “low-functioning” autistic children: a pilot study’, Biol Psychiatry 1999 Aug 1; 46(3):420-424
Altman DG, Bland JM, ‘Absence of evidence is not evidence of absence’, Br Med J, 1995;311:485
American Academy of Pediatrics and US Public Health Service, July 8, 1999, 'Thimerosal, a Mercury-containing Preservative Used in Some Vaccines'
American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Washington D.C., 1994
Amin-Zaki L, Majeed MA, Clarkson TW, Greenwood MR, ‘Methylmercury poisoning in Iraqi children: clinical observations over two years’, British Medical Journal 1978 March 1, 613-616
Amin-Zaki L, Majeed MA, Elhassani SB, Clarkson TW, Greenwood MR, Doherty RA, ‘Prenatal Methylmercury Poisoning’, American Journal of the Disabled Child, 1979 Feb 133:172-177
Amin-Zaki, L, Elhassani S, Majeed MA, Clarkson TW, Doherty RA, Greenwood M, ‘Intra-uterine methylmercury poisoning in Iraq’, Pediatrics 1974 Nov 54:5587-595
Anuradha B, Rajeswari M, Varalakshmi P, ‘Degree of peroxidative status in neuronal tissues by different routes of inorganic mercury administration’, Drug Chem Toxicol 1998 Feb;21(2):47-55
Applied Toxicology, 1992 Apr;12(2):79-84
ARI Newsletter, review, 'Long term follow-up: early intervention effects lasting', 1993 7(1):1&6
Aronow R, Fleischmann L ,‘Mercury Poisoning in Children’, Clinical Pediatrics, 1976 Oct, Vol.15, No.10, 936-945
Arvidsson T, Danielsson B, Forsberg P, Gillberg C, Johansson M, Kjellgren G, ‘ Autism in 3-6 year old children in a suburb in Göteborg, Sweden’, Autism, November 1997, Vol. 1, No. 2, 163-173
Aschner M, Aschner JL, ‘Mercury Neurotoxicity: Mechanisms of Blood-Brain Barrier Transport’, Neuroscience & Behavioral Reviews, 1990, Vol. 14, 169-176
Aschner M, Lorscheider FL, Cowan KS, Conklin DR, Vimy MJ, Lash LH, ‘Methallothionein induction in fetal rat brain and neonatal primary astrocyte cultures by in utero’, Brain Res, Dec 5; 778(1):222-232
Ashour H, Abdel-Rahman M, Khodair A., 1993 ‘The mechanism of methyl mercury toxicity in isolated rat hepatocytes’, Toxicology Letters 1993 Jul;69(1):87-96
Atchison WD and Hare MF, ‘Mechanisms of methylmercury-induced neurotoxicity’, FASEB Journal 1994 Jun;8(9):622-629
Atchison WD, Joshi U, Thornburg JE, ‘Irreversible Suppression of Calcium Entry into Nerve Terminals by Methylmercury’, The Journal of Pharmacology and Experimental Therapeutics, 1986, Vol. 238, No. 2, 618-624
Aukrust P, et al, ‘Decreased levels of total and reduced glutathione in CD4+ lymphocytes in common variable immunodeficiency are associated with activation of the tumor necrosis factor system: possible immunopathogenic role of oxidative stress’, Blood, 1995, 86.4.1383-1391
Aukrust P, et al, 'Persistent activation of the tumor necrosis factor system in subgroup of patients with common variable immunodeficiency - possible immunological and clinical consequences’, Blood, 1996, 97.2.674-681
Aylward EH, Minshew NJ, Goldstein G, Honeycutt NA, Augustine AM, Yates KO, Barta PE, Pearlson GD, 'MRI volumes of amygdala and hippocampus in non-mentally retarded autistic adolescents and adults', Neurology 1999 Dec 10;53(9):2145-50
Bachevalier J, 'Brief Report: Medial Temporal Lobe and Autism: A Putative Animal Model in Primates', Journal of Autism and Developmental Disorders, 1996;26(2):217-220
Bachevalier J, 'Medial Temporal Lobe Structures: a Review of Clinical and Experimental Findings', Neuropsychologia, 1994;32:627-648
Bagenstose LM, Salgame P, Monestier M, ‘Mercury-induced autoimmunity in the absence of IL-4’, Clin Exp Immunol, Oct 1998, 114(1):9-12
Bagenstose LM, Salgame P, Monestier M, ‘Murine mercury-induced autoimmunity: a model of chemically related autoimmunity in humans’, Immunol Res, 1999, 20(1):67-78
Bailey A, Phillips W, Rutter M, ‘Autism: Towards an Integration of Clinical, Genetic, Neuro-psychological, and Neurobiological Perspectives’, J Child Psychol Psychiatry 1996 Jan; 37(1): 89-126.
Bailey A, Luthert P, Dean A, Harding B, Janota I, Montgomery M, Rutter M, Lantos, 'A clinicopathological study of autism', Brain 1998 May;121 ( Pt 5):889-905
Bakir F, Damluji  SF, Amin-Zaki L, Murtadha M, Khalidi A, Al-Rawi NY, Tikrit S, Dhahir HI, Clarkson TW, Smith JC, Doherty RA, ‘Methylmercury poisoning in Iraq’, Science, July 1973, 181;230-241
Baranek G, 'Autism During Infancy:  A Retrospective Video Analysis of Sensory-Motor and Social Behaviors and 9-12 Months of Age', Journal of Autism and Developmental Disorders, 1999, Vol. 29, No. 3, pp. 213-224
Baron-Cohen S, Ring HA, Wheelwright S, Bullmore ET, Brammer MJ, Simmons A, Williams SC, 'Social intelligence in the normal and autistic brain: an fMRI study', Eur J Neuroscience 1999 Jun;11(6):1891-8
Baron-Cohen S, Leslie A, Frith U, ‘Does the autistic child have a ‘theory of mind’?’, Cognition, 1985, No. 21, pp. 37-46
Baron-Cohen S, Allen J, Gillberg C, 'Can autism be detected at 18 months: the needle, the haystack, and the CHAT', Br. J. Psychiatry, 1992;161:839-843
Baron-Cohen S, Tager-Flusberg H, Cohen D, Understanding Other Minds: Perspectives from Autism, Oxford: Oxford University Press, 1993
Barregard L, Sallsten G, Conradi N, ‘Tissue levels of mercury determined in a deceased worker after occupational exposure’, Int Arch Occup Environ Health 1999 May;72(3):169-173
Bartolome J, Whitmore WL, Seidler FJ, Slotkin TA 1984 ‘Exposure to methylmercury in utero: effects on biochemical development of catecholamine neurotransmitter systems’, Life Sciences 1984 Aug 6;35(6):657-670
Bauman ML, Kemper TL, 'Neuroanatomical observations of the brain in autism', in Bauman & Kemper, eds, The Neuroanatomy of Autism, The Johns Hopkins University Press
Bauman ML and Kemper TL, Journal of Experimental Neurology, 1988 47:369
Bauman M, Kemper TL, 'Histoanatomic observations of the brain in early infantile autism', Neurology, 1985;35:866-874
Bernabei P, Camaioni L, Levi G, ‘An evaluation of early development in children with autism and pervasive developmental disorders from home movies: preliminary findings’, Autism, September 1999, Vol. 2, No. 3, 243-258
Bettleheim B, 'A letter from Bruno Bettleheim', Autism Research Review International, 1989,  Vol 3,  No. 3, p. 6
Bidet B, Leboyer M, Descours B, Bouvard MP, Benveniste J, ‘Allergic sensitization in infantile autism’ (letter), Journal of Autism and Developmental Disorders, June 1993, Vol. 23, No. 2, pp. 419-420
Binstock T, 'Fragile X and the amygdala: cognitive, interpersonal, emotional, and neuroendocrine considerations', Dev Brain Dysfunction 1995 8:199-217
Bonnet JJ, Benmansour S, Amejdki-Chab N, Costentin J, ‘Effect of CH3HgCl and several transition metals on the dopamine neuronal carrier; peculiar behaviour of Zn2+’, Eur J Pharmacol 1994 Jan 1;266(1)87-97
Bouilleret V, Boyet S, Marescaux C, Nehlig A, ‘Mappingof the progressive metabolic changes occurring during the development of hippocampal sclerosis in a model of mesial temporal lobe epilepsy’, Brain Research, 2000, 952:255-262
Brenner RP and Snyder RD, ‘Late EEG finding and clinical status after organic mercury poisoning’, Archives of Neurology 1980 May; 37(5):282-284
Bristol M, Cohen D, Costello E, Denckla M, Eckberg T, Kallen R, Kraemer H, Lord C, Maurer R, McIlvane W, Minshew N, Sigman M, Spence M, 'State of the Science in Autism: Report to the National Institutes of Health' , Journal of Autism and Developmental Disorders, 1996, Vol. 26, No. 2, pp. 121-157
Bryson SE, ‘Brief Report: Epidemiology of Autism’, Journal of Autism and Developmental Disorders, 1996, Vol. 26, No. 2, 165-167
Bryson SE, Smith IM, Eastwood D, 'Obstetrical suboptimality in autistic children', J Am Acad Child Adolesc Psychi, 1988;27(4)418-22
Bulleit RF, Cui H, ‘Methylmercury antagonizes the survival-promoting activity of insulin-like growth factor on developing cerebellar granule neurons’, Toxicol Appl Pharmacol 1998 Dec;153(2):161-168.
Cagiano R, De Salvia MA, Renna G, Tortella E, Braghiroli D, Parenti C, Zanolie P, Baraldi M, Annau Z, Cuomo V, ‘Evidence that exposure to methyl mercury during gestation induces behavioral and neurochemical changes in offspring of rats’, Neurotoxicol Teratol 1990 Jan-Feb;12(1):23-28
Camerino , Cassitto M, 'Behavior of Some Psychological Parameters of a Population of a Hg Extraction Plant', Journal of Clinical Toxicology, 1981, Vol. 18 (11), pp. 1299-1309
Capps L, Kehres J, Sigman M, 'Conversational abilities among children with autism and children with developmental delays', Autism, 1998 Dec;2(4):325-44
Carlsson ML, ‘Hypothesis: is infantile autism a hypoglutamatergic disorder? Relevance of glutamate - serotonin interactions for pharmacotherapy’, Journal of Neural Transmitters 1998 105(4-5):525-535
Carlsson ML, Martin P, Nilsson M, Sorensen SM, Carlsson A, Waters S, Waters N, ‘The 5-HT2A receptor antagonis M100907 is more effective in counteracting NMDA antagonist- than dopamine agonist-induced hyperactivity in mice’, J Neural Transm 1999; 106(2):123-129
Carpenter PK, Morris D, ‘Association of acrocyanosis with Asperger’s syndrome’, Journal of Mental Deficiency Research, 1990, 34, pp. 97-90
CDC, ‘Recommendations Regarding the Use of Vaccines That Contain Thimerosal as a Preservative’, MMWR November 5, 1999 / 48(43); 996-998
CDC, ‘Thimerosal in vaccines: a joint statement of the Amercian Academy of Pediatrics and the Public Health Service’, MMWR Morb Mortal Wkly Rep 1999 July 9; 48(26):563-565
CDC, 'Record Immunization Rate, 80% of Kids Getting Vaccinated', Associated Press, September 23, 1999
Cesaroni L, Garber M, 'Exploring the experience of autism through firsthand accounts', Journal of Autism and Developmental Disorders, 1991 Sep;21(3):303-13
Chapman AG, Elwes RD, Millan MH, Polkey CE, Meldrum BS, 'Role of Glutamate and Aspartate in Epileptogenesis; Contribution of Microdialysis Studies in Animal and Man', Epilepsy Res Suppl, 1996, Vol. 12, pp. 239-246
Cheek DB, 'Acrodynia', in Brennemann's Practice of Pediatrics, Chapter 17D, from Pink Disease website,
Chodorowski Z, Sein Anand J, Nowicki A, Galant K, ‘Subcutaneous self-injection and oral self-administration of metallic mercury - case report’, Przegl Lek 1997;54(10):759-762
Chu CC, Huang CC, Ryu SJ, Wu TN, ‘Chronic inorganic mercury induced peripheral neuropathy’, Acta Neurology Scandanavia 1998 Dec;98(6):461-465
Chugani DC, Muzik O, Behen M, Rothermel R, Janisse JJ, Lee J, Chugani HT, ‘Developmental Changes in Brain Serotonin Synthesis Capacity in Autistic and Nonautistic Children’, Ann Neurol 1999; 45:
Church C, Coplan J, 'The High Functioning Autistic Experience: Birth to Preteen Years', Journal of Pediatric Health Care, 1995, Vol. 9, pp.22-29
Clarke D, Baxter M, Perry D, Prasher V, 'The diagnosis of affective and psychotic disorders in adults with autism: seven case reports', Autism, 1999 Jun;3(2):149-164
Clarkson TW, ‘Mercury: Major Issues in Environmental Health’, Environmental Health Perspectives vol. 100, pp. 31-38, 1992
Clarkson, T. 1997 ‘The Toxicology of Mercury’, Critical Reviews in Clinical Laboratory Sciences, 34(3): 369-403 (1997)
Clarkson, TW, ‘Mercury - an element of mystery’, The New England Journal of Medicine 1990 Oct 18
Clarkson,T.W, 1993, 'Molecular and ionic mimicry of toxic metals', Annu. Rev. Pharmacol. Toxicol. 32:545-571
Cloarec S, Deschenes G, Sagnier M, Rolland JC, Nivet H, ‘Arterial hypertension due to mercury poisoning: diagnostic value of captopril’, Arch Pediatr 1995 Jan;2(1):43-46
Close AH, Guo TL, Shenker BJ, ‘Activated human T lymphocytes exhibit reduced susceptibility to methylmercury chloride-induced apoptosis’, Toxicol Sci 1999 May;49(1):68-77
Coccini T, Randine G, Candura SM, Nappi RE, Prockop LD, Manzo L, ‘Low-Level Exposure to Methylmercury Modifies Muscarinic Cholinergic Receptor Binding Characteristics inRat Brain and Lymphocytes: Physiologic Implications and New Opportunities in Biologic Monitoring’, Environ Health Perspect, 2000 Jan;108(1):29-33
Coleman M, ‘Nutritional treatments currently under investigation in autism’, Clinical Nutrition, Sept/Oct 1989, Vol. 8, No. 5, pp. 210-212
Comi AM, Zimmerman A et al, 'Familial clustering of autoimmune disorders and evaluation of medical risk factors in autism', Journal of Child Neurology, 1999, Vol. 14, pp. 388-394
Connolly AM, et al, ‘Serum autoantibodies to brain in Landau-Kleffner variant, autism, and other neurologic disorders’, Journal of Pediatrics, May 1999, Vol. 134, No. 5, pp. 607-613
Cook EH, ‘Autism: review of neurochemical investigation’, Synapse, 1990, 6:292-308
Courchesne E, et al,‘More evidence links autism, cerebellar defects’, reviewed in Autism Research Review International, 1994, Vol. 8, No. 2, pp. 1&7
Courchesna E, Press GA, Young-Courchesne R, 'Parietal lobe abnormalities detected with MR in patients with infantile autism', AJR Am J Roentgenol 1993 Feb;160(2):387-93
Courchesne E, 'Brainstem, cerebellar and limbic neuroanatomical abnormalities in autism', Current Opin Neurobiol 1997 Apr;7(2):269-78
Courchesne E, Saitoh O, Townsend J, Yeung-Courchesne R, Lincoln AJ, Schreibman L, Haas RH, Press GA, 'Cerebellar Abnormalities in Autism: New Evidence and A Re-Analysis of Old Evidence', pp. 211-214
Courchesne E, Yeung-Courchesne R, Elmasian R, Grillon C, 'Pathophysiologic findings in non-retarded autism and receptive developmental language disorder', Journal of Autism and Developmental Disorders, 1989; 19:1-17
Courchesne E, Yeung-Courchesne R, Press GA, Hesselink JR, Jernigan TL, ‘Hypoplasia of cerebellar vermal lobules VI and VII in autism’, New England Journal of Medicine 1988 318:1349-1354
Courchesne E, Yeung-Courchesne R, Press GA, Hesselink JR, Jernigan TL, ‘Hypoplasia of cerebellar vermal lobules VI and VII in autism’, New England Journal of Medicine, May 26, 1998; pp. 1349-1354
Courchesne E, reported in The New York Times, 'Science Times' section, Dec 28, 1999, by Blakeslee S
Cox NH, Forsyth A, ‘Thiomersal allergy and vaccination reactions’, Contact Dermatitis 1988:18:229-233
Creel DJ, Crandall AS, Pingree C, Ritvo ER, 'Abnormal electroretinograms in autism', Clinical Vision Science 1989 4(1):85-88
Cuomo V, Ambrosi L, Annau Z, Cagiano R, Brunello N, Racagni G 1984, ‘Behavioral and neurochemical changes in offspring of rats exposed to methyl mercury during gestation’, Neurobehavior Toxicology Teratol 1984 May-June;6(3):249-254
D’Eufemia P, Celli M, Finocchiaro R, Pacifico L, Viozzi L, Zaccagnini M, Cardi E, Giardini O, ‘Abnormal intestinal permeability in children with autism’, Acta Pædiatr 1996:85:1076-1079
D’Eufemia P, Finocchiaro R, Celli M, Viozzi L, Monteleone D, Giardini O, ‘Low serum tryptophan to large neutral amino acids ratio in idiopathic infantile autism’, Biomed. & Pharmacother., 1995, Vol. 49, pp. 288-292
Dales LD, ‘The Neurotoxicity of Alkyl Mercury Compounds’, American journal of Medicine, August 1972, Vol. 53, 219-232
Dally A, 'The Rise and Fall of Pink Disease', Wellcome Institute for the History of Medicine, 1997, available at
Dathan JG, 'Pink Disease-Ten Years After (The Epilogue), British Medical Journal, 1965, Vol 1, pp. 1181-1182
Dave V, Mullaney KJ, Goderie S, Kimelberg HK, Aschner M, ‘Astrocytes as mediators of methylmercury neurotoxicity: effects on D-aspartate and serotonin uptake’, Dev Neurosci 1994;16(3-4):222-231
Davis LE, Kornfeld M, Mooney HS, Fiedler KJ, Haaland KY, Orrison WW, Cernichiari E, Clarkson TW, ‘Methylmercury poisoning: long term clinical, radiological, toxicological, and pathological studies of an affected family’, Annals of Neurology 1994 35:6 680-688
Dawson G, ‘Brief Report: Neuropsychology of Autism: A Report on the State of the Science’, Journal of Autism and Developmental Disorders, 1996, Vol. 26, No. 2, 179-184
Deb S and Thompson B, ‘Neuroimaging in autism’, British Journal of Psychiatry 1998 Oct 173:299-302
DelGiuidce-Asch G, Hollander E, ‘Altered immune function in autism’, CNS Spectrums: International Journal of Neuropsychiatric Medicine, 1997, 2:61-68
DeLong GR, ‘Autism: new data suggest a new hypothesis’, Neurology, March 1999, Vol. 52, No. 5, pp. 911-916
Deutsch S, Campbell M, Sachar E, Green W, David R, ‘Plasma growth hormone response to oral L-dopa in infantile autism’, Journal of Autism and Developmental Disorders, June 1985, Vol. 15, No. 2, pp. 205-212
Deyab P, Gochfeldbc M, Reuhlabca K, 'Developmental Methylmercury Administration Alters Cerebellar PSA-NCAM expression and Golgi sialyltransferase Activity', 1999
Diner Barry, M.D., Brenner Barry, M.D.,Toxicity, Mercury, 1998
Edelson MG, Edelson SM, Jung S, ‘Assessing the Intelligence of Individuals with Autism: A Cross-Cultural Replication of the Usefulness of the TONI’, Focus on Autism and Other Developmental Disabilities, Winter 1998, Vol. 13, No. 4, 221-227
Edelson MG, Schubert DT, Edelson SM, ‘Factors Predicting Intelligence Scores on the TONI in Individuals with Autism’, Focus on Autism and Other Developmental Disabilities, Spring 1998, Vol. 13, No. 1, 17-26
Edelson SB, Cantor DS, ‘Autism: xenobiotic influences’, Toxicol Ind Health, 1998 Jul-Aug;14(4):553-563
Egan, William M. 1999 ‘Thimerosal in Vaccines’, presentation to the FDA, September 14, 1999
Eisenmayer R et al, 'Delayed language onset as a predictor of clinical symptoms in pervasive developmental disorders', Journal of Autism and Developmental Disorders, 1998 Dec 28(6):527-33
El-Fawal HA, Waterman SJ, De Feo A, Shamy MY, ‘Neuroimmunotoxicology: Humoral Assessment of Neurotoxicity and Autoimmune Mechanisms’, Environ Health Perspect 1999 Oct;107(Suppl 5):767-775
Elferink JG Thimerosal: a versatile sulfhydryl reagent,calcium mobilizer, and cell function-modulating agent.Gen Pharmacol 1999 Jul;33(1):1-6
Environmental Protection Agency (EPA), lead authors - Hassett-Sipple B, Swartout J, Schoeny R, 'Vol. V - Health Effects of Mercury and Mercury Compounds', Mercury Study Report to Congress, December 1997
Ernst M, Zametkin AJ, Matochik JA, Pascualvaca D, Cohen RM, 'Low medial prefrontal dopaminergic activity in autistic children', Lancet 1997 Aug 30;350(9078):638
Eto K, Takizawa Y, Akagi H, Haraguchi K, Asano S, Takahata N, Tokunaga H, ‘Differential diagnosis between organic and inorganic mercury poisoning in human cases - the pathologic point of view’, Toxicol Pathol 1999 Nov-Dec;27(6):664-671
Fagala GE,Wigg CL, ‘Psychiatric Manifestions of Mercury Poisoning’, J. Am. Acad. Child. Adolesc. Psychiatry, March 1992,  31(2):306-311.
Fagan DG, Pritchard JS, Clarkson TW, Greenwood MR, ‘Organ mercury levels in infants with omphaloceles treated with organic mercurial antiseptic’, Archives of Disease in Childhood, 1977 52:962-964
Farnsworth D, ‘Pink Disease Survey Results’, Pink Disease Support Group Site, 1997
Faro LR, Duran R, do Nascimento JL, Alfonso M, Picanco-Diniz CW, ‘Effects of methyl mercury on the in vivo release of dopamine and its acidic metabolites DOPAC and HVA from Striatum of rats’, Ecotoxicol Environ Saf 1997 Nov;38(2):95-98
Faro LRF, Nascimento JLM do, Alfonso M, Duran R, ‘Acute Administration of Methylmercury Changes In Vivo Dopamine Release from Rat Striatum’, Bulletin of Environmental Contamination Toxicology, 1998 60:632-638
FDA, HHS, ‘Mercury Containing Drug Products for Topical Antimicrobial Over-the-Counter Human Use; Establishment of a Monograph’, Federal Register, January 5 1982, Vol. 47, No. 2, 436-442
FDA, 'Mercury Compounds in Drugs and Food', 98N-1109, November 16, 1999
Feldman R, 'Neurological Manifestations of Mercury Intoxication', Journal of Occupational Neurology, 1982, Vol. 66, pp. 201-209
Filipek P, Accardo P, Baranek G, Cook E, Dawson G, Gordon B, Gravel J, Johnson C, Kallen R, Levy S, Minshew N, Prizant B, Rapin I, Rogers S, Stone W, Teplin S, Tuchman R, Volkmar F, 'The Screening and Diagnosis of Autistic Spectrum Disorders', Journal of Autism and Developmental Disorders, 1999, Vol. 29, No. 6, pp. 439-484
Finegan J, Quarrington B, 'Pre-, peri-, and neonatal factors and infantile autism', J Child Psychol Psychi, 1979; 20.119-128
Florentine MJ and Sanfilippo II DJ, ‘Grand Rounds: Elemental mercury poisoning’, Clinical Pharmacy 1991 Mar 10:213-221
Fombonne E, Rogé B, Claverie J, Courty S, Frémolle J, ‘Microcephaly and Macrocephaly in Autism’ Journal of Autism and Developmental Disorders, 1999, Vol. 29, No. 2, 113-119
Food and Drug Administration, 1997 ‘Status of Certain Additional Over-the-Counter Drug Category II and III Active Ingredients’, Docket Nos. 75N-183F, 75N-183D, and 80N-0280, October 19,1998
Fournier L, Thomas, G, Garnier, R, Buisine, A, Houze, P, Pradier, F, and Dally, S 1988, ‘2,3-Dimercaptosuccinic Acid Treatment of Heavy Metal Poisoninig in Humans’, Medical Toxicology 3: 499-505 (1988)
Frackelton JP, Christensen RL, ‘Mercury Poisoning and Its Potential Impact on Hormone Regulation and Aging: Preliminary Clinical Observations Using a New Therapeutic Approach’, Journal of Advancement in Medicine 1998 Spring 11(1):9-25
Fredriksson A, Dencker L, Archer T, Danielsson BGR, ''Prenatal coexposure to metallic mercury vapour and methylmercury produce interactive behavioural changes in adult rats', Neurotoxicol Teratol 1996 19(2):129-134
Fuchs J, Packer L, Zimmer G, Lipoic Acid in Health and Disease, Marcel Dekker, Inc., 1997
Fuchs J, Schöfer H, ‘Redox Modulation of Signal Transduction and Gene Expression in HIV Infection: The Role of the Antioxidant Lipoate’, Lipoic Acid in Health and Disease, Fuchs, Packer, & Zimmer (eds), Marcel Dekker, Inc., 1997, 435-454
Fudenberg HH, ‘Dialysable Lymphocyte Extract (DLyE) in Infantile Onset Autism: A Pilot Study’, Biotherapy (1996) 9:143-147
Fukino H, Hirai M, Hsueh YM, Yamane Y,‘Effect of zinc pretreatment on mercuric chloride-induced lipid peroxidation in the rat kidney’, Toxicol Appl Pharmacol 1984 May;73(3):395-401
Gaffney GR, Kuperman S, Tsai LY, Minchin S, ‘Morphological evidence for brainstem involvement in infantile autism’, Biological Psychiatry, September 1988, 24:578-586
Gilbert SG, Grant-Webster KS, ‘Neurobehavioral effects of developmental methymercury exposure’, Environmental Health Perspectives, 1995 Sept; 103 Suppl 6:135-142
Gillberg C, Coleman M, The Biology of the Autistic Syndromes - 2nd Edition, Mac Keith Press, 1992
Gillberg C, Dev Med Child Neurol 37, 23-45 (1995)
Gillberg C, Gillberg IC, 'Infantile Autism: a total population study of reduced optimality in the pre-, peri- and neonatal period', Journal of Autism and Developmental Disorders, 1983, Vol 13, No. 2, pp. 153-166
Gillberg C, Svennerholm L, ‘CSF monoamines in autistic syndromes and other pervasive dev. disorders of early childhood’, British Jour. of Psychiatry, 1987, No. 151, pp. 89-94
Gillberg C, Wing L, ‘Autism: not an extremely rare disorder’, Acta Psychiatr Scand 1999 Jun;99(6)399-406
Goldberg M, Mena I, Miller B, ‘Frontal and temporal lobe dysfunction in autism and other related disorders: ADHD and OCD’, Latin American Journal of Nuclear Medicine, July 1999, available online:
Golse B, Debray-Ritzen P, Durosay P, Puget K, Michelson AM, ‘Alterations in two enzymes: superoxide dismutase and glutathion peroxidase in developmental infantile psychosis’, Revue Neurologic (Paris) 1978 Nov;134(11):699-705
Gosselin RE, Smith RP, Hodge HC, Clinical Toxicology of Commercial Products, Section III, Therapeutic Index, 'Mercury',  (5th edition),  Baltimore, Williams & Wilkins, 1984: pp262-271.
Grandin T, ‘Brief Report: Response to National Institutes of Health Report’, Journal of Autism and Developmental Disorders, 1996, Vol. 26, No. 2, 185-187
Grandin T, ‘The Learning Style of People With Autism: An Autobiography’, Teaching Children with Autism, Kathleen Ann Quill, 33-52
Grandjean P, Budtz-Jorgensen E, White RF, Jorgensen PJ, Weihe P, Debes F, Keiding N, ‘Methylmercury exposure biomarkers as indicators of neurotoxicity in children aged 7 years’, Am J Epidemiol 1999 Aug 1; 150(3):301-305
Grandjean P, Guldager B, Larsen IB, Jergensen PJ, Holmstrup P, ‘Placebo Response in Environmental Disease’, JOEM 1997 August, Vol. 38, No. 8,707-714
Grandjean P, Weihe P, White RF, Debes F, ‘Cognitive performance of children prenatally exposed to “safe” levels of methylmercury’, Environmental Research 1998 May; 77(2): 165-172
Grandjean P, White RF, Nielsen A, Cleary D, de Oliveira Santos EC, ‘Methylmercury neurotoxicity in Amazonian children downstream from gold mining’, Environ Health Perspect 1999 Jul;107(7):587-591
Grundt IK, Stensland E, Syverson TL, ‘Changes in fatty acid composition of myelin cerebrosides after treatment of the developing rat with methylmercury chloride and diethylmercury’. J Lipid Res, 1980 Feb;21(2):162-168
Gunderson, VM, Grant KS, Burbacher TM, Fagan 3rd JF, Mottet, NK, ‘The effect of low-level prenatal methyl mercury exposure on visual recognition memory in infant’, Child Dev., 1986, 57(4):1076-1083
Gunderson, VM, Grant KS, Burbacher TM, et al, ‘Visual recognition memory deficits in methyl mercury exposed Macaca fascicularis infants’, Neurotoxicol Teratol., 1988, 10(4):373-379
Gupta S, Aggarwal S, Heads C, ‘Brief Report: Dysregulated Immune System in Children with Autism: Beneficial Effects of Intravenous Immun Globulin on Autistic Characteristics’, Journal of Autism and Developmental Disorders, 1996, Vol. 26, No. 4, 439-452
Gupta S, Aggarwal S, Rashanravan B, Lee T, ‘Th1- and Th2-like cytokines in CD4+ and CD8+ T cells in autism’, J Neuroimmunol 1998 May 1;85(1):106-109
Haeney MR, Carter GF, Yeoman WB, Thompson RA, ‘Long-term parental exposure to mercury in patients with hypogammaglobulinaemia’, British Medical Journal 1979 2:12-14
Hagerman RJ, 'Possible similarities between the fragile X and Asperger syndrome', American Journal of Diseases of Children, 1987;141:601-602
Halsey NA, 'Perspective on the use of thimerosal-containing vaccines', presentation at the National Vaccine Advisory Committee Workshop on Thimerosal and Vaccines, August 11-12, 1999, available on  Institute of Vaccine Safety website,
Halsey NA, ‘Limiting Infant Exposure to Thimerosal in Vaccines and Other Sources of Mercury’, JAMA, November 10, 1999, Vol. 282, No. 18
Hartman DE, 'Missed diagnoses and misdiagnoses of environmental toxicant exposure', Diagnostic Dilemmas, Part I, 1998 Sep;21(3):659-671
Hashimoto T, Tayama M, Miyazaki M, Sakurama N, Yoshimoto T, Murakawa K, Kuroda Y, ‘Reduced brainstem size in children with autism’, Brain & Development, 1992, Vol. 14, No. 2, pp. 94-97
Hashimoto T, Tayama M, Murakawa K, Yoshimoto T, Miyazaki M, Harada M, Kuroda Y, ‘Development of the brainstem and cerebellum in autistic patients’, Journal of Autism and Developmental Disorders, 1995, Vol. 25, No. 1, pp. 1-18
Haznedar MM, Buchsbaum MS, Metzger M, Solimando A, Spiegel-Cohen J, Hollander E, ‘Anterior Cingulate Gyrus Volume and Glucose Metabolism in Autistic Disorder’, Amercian Journal of Psychiatry 1997 Aug 154(8):1047-1050
Hepatitis Control Report, ‘Uproar over a little-known preservative, thimerosal, jostles U.S. hepatitis B vaccination policy’, Summer 1999, Vol. 4, No. 2
Hollander E, Kaplan A, Cartwright C, Reichman D, ‘Venlafaxine in children, adolescents, and young adults with autism spectrum disorders: an open retrospective clinical report’, J Child Neurol, 2000, Feb;15(2):132-135
Hoon AH and Riess AL, ‘The mesial-temporal lobe and autism: case report and review’, Developmental Medicine and Child Neurology 1992 34:252-265
Horvath K, Papadimitriou JC, Rabsztyn A, Drachenberg C, Tildon JT, ‘Gastrointestinal abnormalities in children with autistic disorder’, Journal of Pediatrics 1999 Nov 135(5):559-563
Hoshino Y, Watanabe M, Kumashiro H, ‘The hypothalamo-pituitary function in autistic children: the change of serum 5HT, plasma human growth hormone, prolactin level after L-5HTP loading’, Neurosciences, 1984, Vol. 10, pp. 285-291
Hoshino Y, Watanabe M, Kumashiro H, ‘The TRH and LH-RH loading test in autistic children’, Journal of Medical Science, 1985, Vol. 31, No. 1
Howlin P, 'Outcome in adult life for more able individuals with autism or Asperger syndrome', Autism 2000 Mar;4(1):63-84
Hrdina PD, Peters DA, Singhal RL 1976, ‘Effects of chronic exposure to cadmium, lead and mercury of brain biogenic amines in the rat’, Research Communications in Chemistry, Pathology and Pharacology 1976 Nov;15(3):483-493
Hu H, Abedi-Valugerdi M, Moller G, ‘Pretreatmet of lymphocytes with mercury in vitro induces a response in T cells from genetically determine low-responders and a shift of the interleukin profile’, Immunology, 1997 90:198-204
Hu H, Möller G, Abedi-Valugerdi M, ‘Major histocompatibility complex class II antigens are required for both cytokine production and proliferation induced by mercuric chloride in vitro’, J Autoimmun, Oct 1997, 10(5):441-446
Hu H, Moller G, Abedi-Valugerdi M, ‘Mechanism of mercury-induced autoimmunity: both T helper 1- and T helper 2-type responses are involved’, Immunology, March 1999, 96(3):348-357
Hua MS, Huang CC, Yang YJ, 'Chronic elemental mercury intoxication: neuropsychological follow up case study', Brain Inj 1996 May;10(5):377-84
Hultman P, Hansson-Georgiadis H, ‘Methyl mercury-induced autoimmunity in mice’, Toxicol Appl Pharmacol, Feb 1, 1999, 154(3):203-211
Hultman P, Nielsen JB, ‘The effect of toxicokinetics on murine mercury-induced automimunity’, Environ Res, May 1998, 77(2):141-148
Hultman P, Turley SJ, Eneström S, Lindh U, Pollard KM, ‘Murine genotype influences the specificity, magnitude and persistence of murine mercury-induced autoimmunity’, J Autoimmun, April 1996, 9(2): 139-149
Hussain S, Atkinson A, Thompson SJ, Khan AT, ‘Accumulation of mercury and its effect on antioxidant enzymes in brain, liver, and kidneys of mice’, J Environ Sci Health B 1999 Jul;34(4):645-660
Ikeda M, Komachi H, Sato I, Himi T, Yuasa T, Murota S, ‘Induction of neuronal nitric oxide synthase by methylmercury in the cerebellum’, Journal of Neuroscience Research 1999 Feb 1;55(3):352-356.
Ikeda M, Komachi H, Sato I, Himi T, Yuasa T, Murota S, ‘Induction of neuronal nitric oxide synthase by methylmercury in the cerebellum’, J Neurosci Res 1999 Feb 1;55(3):352-356
Ilback NG, ‘Effects of methyl mercury exposure on spleen and blood natural-killer (NK) cell-activity in the mouse’, Toxicology, 1991, 67(1):117-124
Islam MS, Berggren PO, Larsson O, ‘Sulfhydryl oxidation induces rapid and reversible closure of the ATP-regulated K+ channel in the pancreatic beta cell’, FEBS Lett 1993 Mar 15;319(1-2):128-132
Jaffe JS, et al, ‘Functional abnormalities of CD8+ t cells define a unique subset of patients with common variable immunodeficiency’, Blood, 1993, 82.1.192-2001
Jaselskis C, Cook E, Fletcher K, and Bennett L, ‘Clonidine treatment of hyperactive and impulsive children with autistic disorder’, Journal of Clinical Psychopharmacology 1992
Johansson U, Hansson-Georgiadis H, Hultman P, ‘The genotype determines the B cell response in mercury-treated mice’, Int Arch Allergy Immunol, Aug 1998, 116(4):295-305
Joselow MM, Louria DB, Browder AA, ‘Mercurialism: Environmental and Occupational Aspects’, Annals of Internal Medicine 1972 76:119-130
Joseph SK, Ryan SV, Pierson S, Renard-Rooney D, Thomas AP, ‘The effect of mersalyl on inositol trisphosphate receptor binding and ion channel function’, J Biol Chem 1995 Feb 24;270(8):3588-3593
Journal of Autism and Developmental Disorders, 1995, Vol. 25, No. 2
Kabuto M,‘Chronic effects of methylmercury on the urinary excretion of catecholamines and their responses to hypoglycemic stress’, Arch Toxical 1991;65(2):164-167
Kanner L, ‘Autistic Disturbances of Affective Contact’, The Nervous Child 1942-1943, Vol. 2, No. 3, 217-250
Karhapaa l, Titievsky A, Kaila K, Tornquist K, ‘Redox modulation of calcium entry and release of intracellular calcium by thimerosal in GH4C1 pituitary cells’, Cell Calcium 1996 Dec;20(6):447-457
Kark RA, Poskanzer DC, Bullock JD, Boylen G. ‘Mercury poisoning and its treatment with N-acetyl-D, L-penicillamine’, New England Journal of Medicine 1971;285:10-16
Kates WR, Mostofsky SH, Zimmerman AW, Mazzocco MM, Landa R, Warsofsky IS, Kaufmann WE, Reiss AL, ‘Neuroanatomical and neurocognitive differences in a pair of monozygous twins discordant for strictly defined autism’, Ann Neurol 1998 Jun; 43(6):782-791
Kinoshita Y, Ohnishi A, Kohshi K, Yokota A, ‘Apparent diffusion coefficient on rat brains and nerves intoxicated with methylmercury’, Environ Res 1999 May;80(4):348-354.
Klin A, Sparrow SS, de Bildt A, Cicchetti DV, Cohen DJ, Volkmar FR, 'A Normed Study of Face Recognition in Autism and Related Disorders', Journal of Autism and Developmental Disorders December 1999 29:6 499-508
Koegel LK, Koegel RL, Smith A, ‘Variables Related to Differences in Standardized Test Outcomes For Children with Autism’, Journal of Autism and Developmental Disorders, 1997, Vol. 27, No. 3, 233-243
Koos BJ and Longo LD, ‘Mercury toxicity in the pregnant woman, fetus, and newborn infant’, American Journal of Obstetrics and Gynecology 1976 Oct 126(3):390-406
Kugler B, 'The differentiation between autism and Asperger syndrome', Autism, 1998 Mar;2(1):11-32
Kurita H, ‘Infantile autism with speech loss before the age of thirty months’, Journal of the American Academy of Child Psychiatry, 1985, Vol. 24, Issue 2, pp. 191-196
LaCamera RG, LaCamera AC, 'Routine Health Care', Handbook of Autism and Pervasive Developmental Disorders, Cohen D, Donnellan AM, Paul R, eds, 1987 by John Wiley & Sons, Inc., p584-595
Larkfors L, Oskarsson A, Sundberg J, Ebendal T, ‘Methylmercury induced alterrations in the nerve growth factor level in the developing brain’, Brain Res Dev Brain Res 1991 Oct 21; 62(2) 287-291
Leboyer M, Philippe A, Bouvard M, Guilloud-Bataille M, Bondoux D, Tabuteau F, Feingold J, Mouren-Simeoni MC, Launay JM, 'Whole blood serotonin and plasma beta-endorphin in autistic probands and their first-degree relatives', Biol Psychiatry 1999 Jan 15;45(2):158-63
Lewine 'Magnetoenchalography in Children with an Autistic Epileptiform Regression', J Pediatrics, 1999 405-418
Lewis MH, ‘Brief Report: Psychopharmacology of Autism Spectrum Disorders’, Journal of Autism and Developmental Disorders, 1996, Vol. 26, No. 2, 231-235
Li S, Thompson SA, Woods JS, ‘Localization of gamma-glutamylcysteine synthetase mRNA expression in mouse brain following methylmercury treatment using reverse transcription in situ PCR amplification’, Toxicol Appl Pharmacol, Sept 1996, 140(1):180-187
Lombard J, ‘Autism: a mitochondrial disorder?’, Medical Hypotheses 1998 Jun;50(6):497-500
Lorscheider FL, Vimy MJ, Summers AO, ‘Mercury exposure from “silver” tooth fillings: emerging evidence questions a traditional dental paradigm’, The FASEB Journal, April 1995, Vol. 9, 504-508
Lowell JA, Burgess S, Shenoy S, Curci JA, Peters M, Howard TK, ‘Mercury Poisoning Associated with High-Dose Hepatitis-B Immune Globulin Administration After Liver Transplantation for Chronic Hepatitis B’, Liver Transplantation and Surgery, Nov 1996, Vol. 2, No. 6, 475-478
Magos L, Brown AW, Sparrow S, Bailey E, Snowden RT, Skipp WR, ‘The comparative toxicology of ethyl- and methylmercury’, Archives of Toxicology, 1985 Sep;57(4):260-267
Malhotra S, Gupta N, 'Childhood Disintegrative Disorder', Journal of Autism and Developmental Disorders Dec 1999 29;6 491-498
Markovich D, Knight D, 'Renal Na-Si Cotransporter NaSi-1 is inhibited by heavy metals', American Journal of Renal Physiology, February 1998, Vol. 274, No. 2, pp283-289
Marty MS, Atchison WD, ‘Elevations of intracellular Ca2+ as a probable contributor to decreased viability in cerebellar granule cells following acute exposre to methyl mercury’, Toxicol Appl Pharmacol 1998 May’ 150(1):98-105
Matheson DS, Clarkson TW, Gelfand EW, ‘Mercury toxicity (acrodynia) induced by long-term injection of gammaglobulin’, Journal of Pediatrics 1980;97(1):153-155.
Mathiesen T, Ellingsen DG, Kjuus H, ‘Neuropsychological effects associated with esposure to mercury vapor among former chloralkali workers’, Scand J Work Environ Health, 1999, Aug:25(4):342-350
Mattsson JR, Miller E, Alligood JP, Koering JE, Levin SG, ‘Early effects of methylmercury on the visual evoked response of the dog’, Neurotoxicology 1981 Nov;2(3):499-514
McClelland RJ, Eyre D, Watson D, Calvert J, ‘A neurophysiological study of autistic children’, Electroencephalography and Clinical Neurophysiology, Sept. 1985, Vol. 61, p. 16
McClelland RJ, Eyre DG, Watson D, Calvert GJ, Sherrard E, British Journal of Psychiatry, 1992, 160:     659-663
McDougle C, Psycholopharmacology, Handbook of Autism and Pervasive Developmental Delay, 2nd ed. New York: John Wiley and Sons, 1997;707:729
McDougle CJ, Brodkin ES, Yeung PP, Naylor ST, Cohen DJ, Price LH, ‘Risperidone in adults with autism or pervasive developmental disorder’, Journal of Child and Adolescent Psychopharmacology, 1995, Vol. 5, No. 4, pp. 273-282
McDougle CJ, Homes JP, Bronson MR, Anderson GM, Volkmar FR, Price LH, Cohen DJ, ‘Risperidone treatment of children and adolescents with pervasive developmental disorders: A prospective open-label study’, Journal of the American Academy of Child and Adolescent Psychiatry, 36, 685-693
McKay SJ, Reynolds JN, Racz WJ, ‘Effects of mercury compounds on the spontaneous and potassium-evoked release of [3H]dopamine from mouse striatal slices’, Canadian Journal of Physiology and Pharmacology 1986 Dec 64(12):1507-1514
McKeown-Eyssen GE, Ruedy J, Neims A, ‘Methyl mercury exposure in northern Quebec: II. Neurologic findings in children’, Am. J. Epidemiol., 1983, 118:470-479
Merck & Co., Inc., ‘Merck Launches Preservative-Free Hepatitis-B Vaccine’, press release, Sept 9, 1999
Messahel S, Pheasant AE, Pall H, Ahmed-Choudhury J, Sungum-Paliwal RS, Vostanis P, ‘Urinary levels of neopterin and biopterin in autism’, Neurosci Lett 1998 Jan 23;241(1):17-20
Minnema DJ, Cooper GP, Greenland RD, ‘Effects of methylmercury on neurotransmitter release from rat brain synaptosomes’, Toxicology and Applied Pharmacology 1989 Jul 99(3):510-521
Minshew NJ, ‘Brief Report: Brain Mechanisms in Autism: Functional and Structural Abnormalities’, Journal of Autism and Developmental Disorders, 1996, Vol. 26, No. 2, 205-209
Moreno H, Borjas L, Arrieta A, Saez L, Prassas A, Estevez J, Bonilla E, ‘Clinical heterogeneity of the autistic syndrome: a study of 60 families’ (Spanish), Invest Clin 1992;33(1):13-31
Moreno-Fuenmayor H, Borjas L, Arrieta A, Valera V, Socorro-Candanoza L, ‘Plasma excitory amino acids in autism’, Invest Clin 1996 Jun;37(2):113-128
Muris P, Steerneman P, Merckelbach H, Holdrinet I, Meesters C, ‘Comorbid anxiety symptoms in children with pervasive developmental disorders’, Journal of Anxiety Disorders, 1998, Vol. 12, No. 4, pp. 387-393
Musiek FE, Hanlon DP, ‘Neuroaudiological effects in a case of fatal dimethylmercury poisoning’, Ear Hear 1999 Jun;20(3):271-275
Nass R, Gross A, Devinsky O, 'Autism and autistic epileptiform regression with occipital spikes',Dev Med Child Neurol 1998 Jul;40(7):453-8
‘Neville’s (a Pinkie) Recollection of Pink Disease’, Pink Disease Support Group,
Nielsen JB and Hultman P, ‘Experimental studies on genetically determined susceptibility to mercury-induced autoimmune response’, Renal Failure 1999 21(3&4):343-348
Nishio H, Nezasa K, Hirano J, Nakata Y, ‘Effects of thimerosal, an organic sulfhydryl modifying agent, on serotonin transport activity into rabbit blood platelets’, Neurochemistry International 1996 29(4):391-396
Nordin V, Gillberg C, ‘Autism Spectrum disorders in children with physical or mental disability or both. I: Clinical and epidemiological aspects’, Dev Med Child Neurol 1996 Apr; 38(4):297-313
Nowell MA, Hackney DB, Muraki AS, Coleman M, 'Varied MR appearance of autism: fifty-three pediatric patients having the full autistic syndrome', Magn Reson Imaging 1990;8(6):811-6
O’Carroll RE, Masterton G. Dougnall N. Ebmeier KP, 1995, ‘The neuropsychiatric sequelae of mercury poisoning: The Mad Hatter’s disease revisited’, British Journal of Psychiatry 167(1):95-98 (1995)
O’Kusky JR, Boyes BE, McGeer EG, ‘Methylmercury-induced movement and postural disorders in developing rat: regional analysis of brain catecholamines and indoleamines’, Brain Research 1988 Jan 26;439(1-2):138-146
O’Neill JL, Through the Eyes of Aliens, Jessica Kingsley Publishers Ltd., 1999
O’Neill M, Jones RSP, ‘Sensory-Perceptual Abnormalities in Autism: A Case For More Research?’, Journal of Autism and Developmental Disorders, 1997, Vol. 27, No. 3, 283-293
O’Reilly BA and Waring, R, ‘Enzyme and sulfur oxidation deficiencies in autistic children with known food/chemical intolerances’, Journal of Orthomolecular Medicine 1993 4:198-200
Ono B, Sakamoto E, ‘Saccharomyces cerevisiae strains sensitive to inorganic mercury. I. Effect of tyrosene’, Curr Genet 1985;10(3):179-185
Ono B, Sakamoto E, Yamaguchi K, ‘Saccharomyces cerevisiae strains sensitive to inorganic mercury. III. Tyrosine uptake’, Curr Genet 1987;11(5):399-406
O'Reilly B,  Waring R,  'Enzyme and Sulphur Oxidation Deficienceies in Autistic Children with Known Food/Chemical Intolerences', pp. 249-252
Ornitz EM, ‘Neurophysiologic Studies of Infantile Autism’, Handbook of Autism and Pervasive Developmental Disorders, John Wiley & Sons, Inc., 1987, 148-165
Otsuka H, 'Brain Metabolites in the Hippocampus-amygdala Region and Cerebellum in Autism: an 1H-MR Spectroscopy Study', Neuroradiology 1999 Jul
Page T, Coleman M, ‘Purine metabolism abnormalities in a hyperuricosuric subclass of autism’, Biochim Biophys Acta, 2000 Mar 17;1500(3):291-296
Page T, Yu A, Fontanesi J, Nyhan WL, ‘Developmental disorder associated with increased cellular nucleotidase activity’, Proc. Natl. Acad. Sci. USA, Vol. 94, October 1997, 11601-11606
Paul R, ‘Natural History’, Handbook of Autism and Pervasive Developmental Disorders, John Wiley & Sons, Inc., 1987, 121-132
Pedersen MB, Hansen JC, Mulvad G, Pedersen HS, Gregersen M, Danscher G, ‘Mercury accumulations in brains from populations exposed to high and low dietary levels of methyl mercury.  Concentration, chemical form and distribution of mercury in brain samples from autopsies’, Int J Circumpolar Health 1999 Apr;58(2): 96-107
Pediatrics 1999; 104:570-574, 'Thimerosal in vaccines: an interim report to clinicians', Committee on Infectious Disease and Committee on Environmental Health
Pendergrass JC, Haley BE, Vimy MJ, Winfield SA, Lorscheider FL, ‘Mercury vapor inhalation inhibits binding of GTP to tubulin in rat brain: similarity to a molecular lesion in Alzheimer diseased brain’, Neurotoxicology 1997;18(2):315-324
Perry E, Lee M, Court J, Perry R, 'Cholinergic Activities in Autism: Nicotinic and Muscarinic Receptor Abnormalities in the Cerebral Cortex' , presentation to Cure Autism Now, 2000
Pfab R, Muckter H, Roider G, Zilker T, ‘Clinical course of severe poisoning with thiomersal’, Clinical Toxicology 1996;34(4):453-460
Pierce PE, Jon F. Thompson, MPH William H. Likosky, MD; Laurance N. Nickey, MD; William F. Barhtel; and Alan R. Hinman, MD, MPH, ‘Alkyl Mercury Poisoning in Humans’, JAMA 1972 Vol 220, No11 1439-1442
Piikivi L, Hanninen H, Martelin T, et al, ‘Psychological performance and long-term exposure to mercury vapors’, Scand. J. Work Environ. Health, 1984, 10:35-41
Piikivi L, Tolonen U, ‘EEG findings in chlor-alkaliworkers subject to low long term exposure to mercury vapor’, Br. J. Ind. Med., 1989, 46(6):370-375
Pirker C, Möslinger T, Wantke F, Götz, Jarisch R, ‘Ethylmercuric chloride: the responsible agent in thimerosal hypersensitivity’, Contact Dermatitis 1993:29:152-154
Piven J, Berthier M, Starkstein S, Nehme E, Pearlson G, Folstein S, ‘Magnetic resonance imaging evidence for a defect of cerebral cortical development in autism’, American Journal of Psychiatry, June 1990, 147:6, pp. 734-739
Piven J, Palmer P, ‘Psychiatric disorder and the broad autism phenotype: evidence from a family study of multiple-incidence autism families’, American Journal of Psychiatry, April 1999, Vol. 156, No. 4, pp. 557-563
Pless R, 'Summary of the Workshop on Thimerosal in Vaccines', Report from the National Immunization Program, CDC, 1999
Plioplys A, 'Autism: Biomedical Perspectives', Presentation for the Autism Society of America meeting, July 1989
Plioplys AV, Greaves A, Kazemi K, Silverman E, ‘Immunoglobin reactivity in autism and Rett’s syndrome’, Developmental Brain Dysfunction, 1994, 7:12-16
Plioplys AV, Greaves A, Kazemi K, Silverman E, ‘Lymphocyte function in autism and Rett Syndrome’, Neuropsychobiology 1994;29(1) :12-6
Plioplys AV, Hemmens SE, Regan CM, 'Expression of a neural cell adhesion molecule serum fragment is depressed in autism', J Neuropsychiatry Clin Neurosci, 1990 Fall;2(4):413-7
Plotkin S, Orenstein W, Vaccines 1999
Prechtl HFR, 'Neurological Findings in Newborn Infants after Pre- and Paranatal complications', Jonxis et al editors:Aspects of Prematurity and Dysmaturity: a Nutrica symposium, Leiden:Stenfert Kroesse, 1968
Prizant BM, ‘Brief Report: Communication, Language, Social, and Emotional Development’, Journal of Autism and Developmental Disorders, 1996, Vol. 26, No. 2, 173-178
Purine Research Society, 'What We Learn About Metabolic Disease Will Benefit Each and Every One of Us', Purine Research Society Website
Puschel G, Mentlein R, Heymann E, 'Isolation and characterization of dipeptidyl peptidase IV from human placenta', Eur J Biochem 1982 Aug;126(2):359-65
Rajanna B and Hobson M, ‘Influence of mercury on uptake of [3H]dopamine and [3H]norepinephrine by rat brain synaptosomes’, Toxicology Letters 1985 Sep 27(1-3):7-14
Rajanna B, Hobson M, Harris l, Ware L, Chetty CS, ‘Effects of cadmium and mercury on Na(+)-K+, ATPase and uptake of 3H-dopamine in rat brain synaptosomes’, Arch Int Physiol Biochim 1990 Oct;98(5):291-296
Rice D, 'Lack of Effect of Methylmercury Exposure from Birth to Adulthood on Information Processing Speed in the Monkey', September 1997,
Rice DC, ‘Sensory and cognitive effects of developmental methylmercury exposure in monkeys, and a comparison to effects in rodents’, NeuroToxicol., 1996, 17:139-154
Rice DC, Gilbert SG, ‘Early chronic low-level methylmercury poisoning in monkeys impairs spatial vision’ Science 1982 May 14;216(4547):759-761
Richdale AL, 'Sleep problems in autism: prevalence, cause, and intervention', Developmental Medicine and Child Neurology, 1999 Jan 41(1):60-6
Rimland B, ‘Recovery from autism is possible’, cited in Autism Research Review International, 1994, Vol. 8, No. 2, p. 3
Rimland B, Baker SM, ‘Brief Report: Alternative Approaches to the Development of Effective Treatments for Autism’, Journal of Autism and Developmental Disorders, 1996, Vol. 26, No. 2, 237-241
Ritvo ER, Freeman BJ, Scheibel AB, Duong T, Robinson H, Guthrie D, Ritvo A, 'Lower Purkinje cell counts in the cerebella of four autistic subjects: intitial findings of the UCLA-NSAC Autopsy Research Report', American Journal of Psychiatry, 1986;143:862-866
Ritvo ER, Freeman BJ, Creel D, Crandall AS, Pingree C, Barr R, Realmuto G, ‘Retinal Pathology in Autistic Children – A Possible Biological Marker for Subtype?’ (letter), Journal of the American Academy of Child Psychiatry, January 1986, 25:137
Rodier PM, Ingram JL, Tisdale B, Croog VJ, ‘Linking etiologies in humans and animal models: studies of autism’, Reproductive Toxicology, 1997, Vol. 11, Nos. 2/3, pp. 417-422
Rodier, P.M., M. Aschner and P. R. Sager. 1984. Mitotic arrest in the developing CNS after prenatal exposure to methyl mercury. Neurobehav. Toxical. Teratol. 6:379-385.
Rogers SJ, ‘Brief Report: Early Intervention in Autism’, Journal of Autism and Developmental Disorders, 1996, Vol. 26, No. 2, 243-246
Rogers T, Kalaydjieva, Hallmayer et al, 'Exclusion of Linkage to the HLA Region in Ninety Multiplex Sibships with Autism', Journal of Autism and Developmental Disorders, 1999 Jun;29(3):195-202
Rohyans J, Walson PD, Wood GA, MacDonald WA, ‘Mercury toxicity following merthiolate ear irrigations’, The Journal of Pediatrics, 1984 Feb:311-313
Romani L, ‘Immunity to Candida albicans: Th1, TH2 cells and beyond’, Curr Opin Microbiol 1999 Aug;2(4): 363-367
Rosenhall U, Johansson E, Gillberg C, ‘Oculomotor findings in autistic children’, Journal of Laryngology and Otology, May 1988, Vol. 102, pp. 435-439
Rosenhall U, Nordin V, Sandstrom M, Ahlsen G, Gillberg C, 'Autism and Hearing Loss', Journal of Autism and Developmental Disorders, Oct 1999 29(5) 349-358
Ross W. Donald, Gechman A, Sholiton M, Paul H, 'Alertness to Neuropsychiatric Manifestations', Comprehensive Psychiatry, Vol. 18, No. 6, pp. 595-598
Rossi AD, Ahlbom E, Ogren So, Nicotera P, Ceccatelli S, ‘Prenatal exposure to methylmercury alters locomotor activity of male but not female rats’, Exp Brain Res 1997 Dec;117(3):428-436
Roux S, Adrien J-L, Bruneau N, Malvy J, Barthelemy C, 'Behavior Profiles within a population of 145 children with autism using the Behaviour Summarized Evaluation scale: influence of developmental age', Autism, 1998 (Dec) 2(4) 235-266
Rumsey J, ‘Conceptual problem-solving in highly verbal, nonretarded autistic men’, Journal of Autism and Dev. Disorders, 1985, Vol. 15, No. 1, pp. 23-36
Rumsey JM, Hamburger SD, ‘Neuropsychological findings in high-functioning men with infantile autism, residual state’, Journal of Clinical and Experimental Neuropsychology, 1988, Vol. 10, No. 2, pp. 201-221
Russell J, Jarrold C, Hood B, ‘Two Intact Executive Capacities in Children with Autism: Implications for the Core Executive Dysfunctions in the Disorder’, Journal of Autism and Developmental Disorders, 1999, Vol. 29, No. 2, 103-112
Rutter M, 'Autism research: prospects and priorities', Journal of Autism and Developmental Disorders 1996 Apr;26(2):257-75
Rutter M, ‘The development of infantile autism’, Psychological Medicine 1974 4:147-163
Ryu YH, Lee JD, Yoon PH, Kim DI, Lee HB, Shin YJ, ‘Perfusion impairments in infantile autism on technetium-99m ethyl cysteinate dimer brain single-photon emission tomography: comparison with findings on magnetic resonance imaging’, Eur J Nucl Med 1999 Mar;26(3):253-259
Sager. P.R., Aschner, M., and Rodier, P.M. 'Persistent differential alteration in developing cerebellar cortex of male and female mice after methylmercury exposure', Dev. Brain Res. 12: 1-11 (1984)
Sarafian TA, Bredesen DE, Verity MA, ‘Cellular resistance to methylmercury’, Neurotoxicology, 1996 Spring Abstract, 17(1):27-36
Sayers LG, Brown GR, Michell RH, Michelangeli F, ‘The effects of thimerosal on calcium uptake and inositol 1,4,5-triosphate-induced calcium release in cerebellar microsomes’, Biochem J 1993 Feb 1;289 (Pt 3):883-887
Schuler AL, ‘Thinking in Autism: Differences in Learning and Development’, Teaching Children with Autism, Kathleen Ann Quill, ed., 1995, 11-32
Sears LL, 'An MRI Study of the Basal Ganglia in Autism', Prog Neuropsychopharmacol Biol Psychiatry, 1999 May
Shafer TJ, Atchison WD, ‘Transmitter, ion channel and receptor properties of pheochromocytoma (PC12) cells: a model for neurotoxicological studies’, Neurotoxicology 1991 Fall;12(3):473-492
Shattock P, Savery D, Autism as a Metabolic Disorder, Autism Research Unit, University of Sunderland, Sunderland, UK, 1997
Shenker BJ, Datar S, Mansfield K, Shapiro IM, ‘Induction of apoptosis in human T-cells by organomercuric compounds: a flow dytometric analysis’, Toxicol Appl Pharmacol, April 1997, 143(2): 397-406
Shenker BJ, Guo TL, Shapiro IM, ‘Low-level methylmercury exposure causes human T-cells to undergo apoptosis: evidence of mitochondrial dysfunction’, Environmental Research, 1998 May; Section A 77(2):149-159
Shenker, B.J., Berthold, P., DeBolt, K., Rooney, C., Vitale, L.A., and Shapiro, I.M. (1992).  'Immunotoxic effects of mercuric compounds on human lymphocytes and monocytes.  II.  Alterations in cell viability',  Immunopharm.  Immunotox. 14, 555-577.
Shenker, B.J., Berthold, P., Decker, S., Mayro, J.S., Rooney, C., Vitale, L.A., and Shapiro, I.M. (1993).  'Immunotoxic effects of mercuric compounds on human lymphocytes and monocytes. III. Alterations in B-cell function and viability',  Immunopharm.  Immunotox. 15, 87-112. 
Siegel BV, Nuechterlein KH, Abel L, Wu JC, Buchsbaum MS, ‘Glucose metabolic correlates of continuous performance test performance in adults with a history of infantile autism, schizophrenics, and controls’, Schizophrenia Research 1995 Sep 17(1):85-94
Sigman M, Ungerer JA, Mundy P, Sherman T, ‘Cognition in Autistic Children’, Handbook of Autism and Pervasive Developmental Disorders, John Wiley & Sons, Inc., 1987, 103-130
Singh VK, 'Plasma increase of Interleuken-12 and Interferon-gamma. Pathological significance in autism', J Neuroimmunology, 1996 May;66(1-2):143-5
Singh VK, Warren RP, Odell D, 'Immune response to brain myelin in autistic children', July 1992
Singh V, Warren R, Odell J, Warren W, Cole P, 'Antibodies to myelin basic protein in children with autistic behavior', Brain, Behavior and Immunity, 1993 Mar;7(1):97-103
Singh VK et al, Biological Psychiatry 1997 41: 753-755
Singh VK, Fudenberg HH, Emerson D, Coleman M, ‘Immunodiagnosis and immunotheraphy in autistic children’, Annals of the New York Academy of Science, 540, 1988, 602-604
Singh VK, Journal of Neuroimmunology 1996 66: 143-145
Singh,VK et al, Brain, Behavior and Immunity 1993 7: 97-103 -
Smalley SL, Collins F, ‘Brief Report: Genetic, Prenatal, and Immunologic Factors’, Journal of Autism and Developmental Disorders, 1996, Vol. 26, No. 2, 195-198
Smith D., 'Mental Effects of Mercury Poisoning',  Presentation before the Section on Family Practice, Southern Medical Association, 71st Annual Scientific Assembly, November 6-9, 1977
Snyder RD.  ‘The involuntary movements of chronic mercury poisoning’, Archives of  Neurology 1972;26:379-3381
Sperry VW, 'Family and personal section: From the inside out - a view of the world as seen by one with Asperger syndrome', Autism, 1998 Marc;2(1):81-86
Sternberg RJ, 'A Unified Theoretical Perspective on Autism', Handbook of Autism and Pervasive Developmental Disorders, Cohen DJ, Donnellan AM, Paul R, eds, 1987 by John Wiley & Sons, p.690-696
Stevenson RE, Schroer RJ, Skinner C, Fender D, Simensen RJ, 'Autism and macrocephaly', Lancet, 1997, 349:1744-1745
Stores G, Wiggs L, 'Abnormal sleeping patterns associated with autism: a brief review of research findings, assessment methods and treatment strategies', Autism, 1998 Jun;2(2):157-170
Stubbs EG, ‘Autistic children exhibit undetectable hemagglutination-inhibition antibody titers despite previous rubella vaccination’, Journal of Autism and Childhood Schizophrenia, 6, 269-274, 1976
Sutton KG, McRory JE, Guthrie H, Murphy TH, Snutch TP, 'P/Q-type calcium channels mediate the activity-dependent feedback of syntaxin-1A', Nature 1999 Oct 21;401(6755):800-4
Szasz A, Barna B, Szupera Z, De Vixxcher G, Galbacx Z, Kirsch-Volders M, Szente M, ‘Chronic low-dose maternal exposure to methylmercury enhances epileptogenicity in developing rats’, Int J. Devl Neurosci, 1999, 17.7.733-742
Szatmari P, Bartolucci G, Bremner R, Bond S, Rich S, ‘A follow-up study of high-functioning autistic children’, Journal of Autism and Developmental Disorders, June 1989, Vol. 19, No. 2, pp. 213-225
Tan XX, Tang C, Castoldi AF, Manzo L, Costa LG, ‘Effects of inorganic and organic mercury on  intracellular calcium levels in rat T lymphocytes’, Journal of Toxicology & Environmental Health, 1993 Feb;38(2):159-170
Teitelbaum P, Teitelbaum O, Nye J, Fryman J, Maurer RG, ‘Movement analysis in infancy may be useful for early diagnosis of autism’, Proc. Natl. Acad. Sci. USA, Vol. 95, November 1998, 13982-13987
The MAAP, Volume IV, 1996; Volume VI, 1996; Volume III, 1999; Volume IV, 1997; Volume II, 1997; Volume I, 1997; Volume II, 1998; Volume IV, 1998, MAAP Services, Inc., PO Box 524, Crown Point, IN 46308
Thrower EC, Duclohier H, Lea EJ, Molle G, Dawson AP, ‘The inositol 1,4,5-trisphosphate-gated Ca2+ channel: effect of the protein thiol reagent thimerosal in channel activity’, Biochem J 1996 Aug 15;318 (Pt 1): 61-66
Tokuomi H. Uchino M. Imamura S. Yamanaga H. Nakanishi R. Ideta T, ‘Minamata disease (organic mercury poisoning):  Neuroradiologic and electrophysiologic studies’,  Neurology 1982;32:1369-1375)
Tonge BJ, Brereton AV, Gray KM, Einfeld SL, 'Behavioural and emotional disturbance in high-functioning autism and Asperger's syndrome', Autism, 1999 Jun;3(2):117-130
Trottier G, Srivastava L, Walker CD, ‘Etiology of Infantile Autism: a review of recent advances in genetic & neurobiological research’, Journal of Psychiatry & Neuroscience, 1999 March 24(2):103-115
Tsai LY, 'Brief Report: Comorbid Psychiatric Dosorders of Autistic Disorder', Journal of Autism and Developmental Disorders, April 1996 26(2)159-164
Tuunanen J, Halonen T, Pitkanen A, ‘Decrease in somatostatin-immunoreactive neurons in the rat amygdaloid complex in a kindling model of temporal lobe epilepsy’, Eiplepsy Res, 1997, 26.315-327
Tuunanen J, Halonen T, Pitkanen A, ‘Status epilepticus causes selective regional damage and loss of GABAergic neurons in the rat amygdaloid complex,’ Eur J Neurosci, 1996, 8:2711-2725
Tuunanen J, Lukasiak K, Halonen T, Pitkanen A, ‘Status epilepticus-induced neuronal damage in the rat amygdaloid complex: distribution, time-course and mechanisms’, Neurosci, 1999, 94.2.473-495
Uchida T, Naito S, Kato H, Hatano I, Harashima A, Terada Y, Ohkawa T, Chino F, & Eto K, ‘Thimerosal induces toxic reaction in non-sensitized animals’, International Archives of Allergy & Immunology, 1994 104(3):296-301
Vahter M, Mottet NK, Friberg L, Lind B, Shen DD, Burbacher T, ‘Speciation of mercury in the primate blood and brain following long-term exposure to methyl mercury’, Toxicol Appl Pharmacol, 1994 Feb;124(2):221-229
Volterra A, Trotti D, Cassutti P, Tromba C, Salvaggio A, Melcangi RC, Racagni G, ‘High sensitivity of glutamate uptake to extracellular free arachidonic acid levels in rat cortical synaptosomes and astrocytes’, Journal of Neurochemistry 1992 Aug 59(2):600-606 -
Von Burg R, Rustam H, ‘Conduction Velocities in Methylmercury Poisoned Patients’, Bulletin of Environmental Contamination & Toxicology, 1974, 12(1):81-85
Von Burg R, Rustam H, ‘Electrophysiological Investigations of Methylmercury Intoxication in Humans. Evaluation of Peripheral Nerve by Conduction Velocity and Electromyography’, Electroencephalography and Clinical Neurophysiology, 1974, 37:381-392
Vostanis P, Smith B, Corbett J, Sungum-Paliwal R, Edwards A, Gingell K, Golding R, Moore A, Williams J, ‘Parental concerns of early development in children with autism and related disorders’, Autism, September 1998, Vol. 2, No. 3, 229-242
Vroom FQ, Greer M, 'Mercury Vapour Intoxication', Brain (1972) 95, 305-318
Wakefield AJ, Murch SH, Anthony A, Linnell J, Casson DM, Malik M, Berelowitz M, Chillon AP, Thomson MA, Harvey P, Valentine A, Davies SE, Walker-Smith JA, ‘Ileal-lymphoid-nodular hyperplasia, non-specific colitis, and pervasive developmental disorder in children’, The LANCET, February 28, 1998, Vol. 351, 637-641
Warfvinge K, Hua J, Logdberg B, 'Mercury distribution in cortical areas and fiber systems of the neonatal and maternal cerebrum after exposure of pregnant squirrel monkeys to mercury vapor', Environ Res 1994 Nov;67(2):196-208
Warkany J, Hubbard DH, 'Acrodynia and Mercury', J Pediatrics 1953 42;365-386
Warren RP, Margaretten NC, Foster A, ‘Reduced Natural Killer Cell Activity in Autism’, Journal of the American Academy of Child and Adolescent Psychiatry, 1987, Vol. 26, No. 3, pp. 333-335
Warren RP, Margaretten NC, Pace NC, Foster A, ‘Immune Abnormalities in Patients with Autism’, Journal of Autism and Developmental Disorders, 1986, Vol. 16, No. 2, pp. 189-197
Warren RP, Odell JD, Warren WL, Burger RA, Maciulis A, Daniels WW, Torres AR, ‘Strong association of the third hypervariable region of HLA-DRß1 with autism’, Journal of Neuroimmunology 67 (1996) 97-102
Warren RP, Yonk LJ, Burger RA, Cole P, Odell JD, Warren WL, White E, Singh VK, 'Deficiency of Suppressor-inducer (CD4+CD45RA+) T Cells in Autism', Immunological Investigations, 1990 Jun 19(3):245-251
Watanabe C, Kasanuma Y, Dejima Y, Satoh H, ‘The effect of prenatal nethylmercury exposure on the GSH level and lipid peroxidation in the fetal brain and placenta of mice’, Tohoku J Exp Med 1999 Feb;187(2):121-126
Watzl B, Abrahamse SL, Treptow-van Lishaut S, Neudecker C, Hansch GM, Rechkemmer G, Pool-Zobel BL, 'Enhancement of ovalbumin-induced antibody production and mucosal mast cell response by mercury', Food Chem Toxicol 1999 Jun;37(6):627-37
Wecker L, Miller SB, Cochran SR, Dugger DL, Johnson WD, ‘Trace Element Concentrations in Hair From Autistic Children’, J. ment Defic. Res. (1985) 29, 15-22
Weitzman A, Weisman R, Szekely GA, Wijsenbeek H, Livni E, 'Abnormal immune response to brain tissue antigen in the syndrome of autism', Am J Psychiatry 1982 Nov;139(11):1462-5
Whiteley P, Rogers J, Shattock P, ‘Clinical features associated with autism: observations of symptoms outside the diagnostic boundaries of autistic spectrum disorders’, Autism, December 1998, Vol. 2, No. 4, 415-422
Wild GC, Benzel EC, Essentials of Neurochemistry, Jones and Bartlett Publishers, Inc., 1994
Williams D, Autism - An Inside-Out Approach, 1996, Jessica Kingsley Publishers Ltd, London
Wing L, Attwood A, ‘Syndromes of Autism and Atypical Development’, Handbook of Autism and Pervasive Developmental Disorders, John Wiley & Sons, Inc., 1987, 3-19
Wing, Lorna (1996) ‘Autism Spectrum Disorder’, British Medical Journal 312: 327-328
Wu J, Takeo T, Kamimura N, Wada J, Suga S, Hoshina Y, Wakui M, ‘Thimerosal modulates the agonist-specific cytosolic Ca2+ oscillatory patterns in single pancreatic acinar cells of mouse’, FEBS Lett 1996 Jul 22;390(2):149-152
Yamagata T, 'FRAXE mental retardation', Nippon Rinsho 1990 Apr;57(4):955-9
Yard BA, Lorentz CP, Herr D, and Van Der Woude F, ‘Sulfation-dependent down-regulation of interferon-gamma-induced Major Histocompatibility Complex I and II Intercellular Adhesion Molecule-1 expression on tubular and endothelial cells by glycosaminoglycans’, Transplantation Vol.66(9), November 15, 1998, pp. 1244-1250
Yazbak FE, ‘Autism ‘99, a national emergency’,   (Internet publication) 1999
Yeates KO & Mortensen ME, ‘Acute and chronic neuropsychological consequences of mercury vapor poisoning in two early adolescents’, Journal of Clinical Exp Neuropsychology, 1994 16(2):209-222
Yip RK, Riley DA, ‘Effects of methylmercury on the motor and sensory and innervation of the rat extensor digitorum longus muscle’, Environ Res 1987 Jun;43(1):85-96.
Yuan Y, and Atchison WD, ‘Comparative effects of methylmercury on parallel-fiber and climbing fiber responses of rat cerebellar slices’, Journal of Pharmacology and Experimental Therapy 1999 Mar;288(3):1015-1025.
Zimmerman A, Brashear R, Frye V, Potter N, 'Anticerebellar Antibodies in Autism', pp. 275-276
Zimmerman A, Frye VH, Potter NT, ‘Immunological aspects of autism’, International Journal of Pediatrics, 8, 1993, 199-204
Zimmerman AW, Gonfardin B, Myers SM, Neuropharmacological therapy in autism, Autism: Clinical and Research Issues, ed. Pasquale Accardo, et al., Timonium, MD: York Press, 1996

Measles (or MMR)
  - Continua QUI: Référes - 1 + Référes - 3 FDA conferma che i Vaccini possono produrre l' Autismo

Danni immunitari con i vaccini: in questa ricerca vi e' la dimostrazione ed evidenza di autoimmunità indotta dal vaccino e autoimmunità indotta anche dagli adiuvanti
Questi meccanismi sono condivisi da diverse condizioni innescate da coadiuvanti portano alla sindrome autoimmune / infiammatoria indotta da adiuvanti (sindrome Asia).
Sindrome infiammatoria chiamata "Asia" scatenata dai vaccini
ASIA_Sindrome infiammatoria-dai-vaccini-Riassunto.pdf
Tratto da:
... ed e' noto che... le infiammazioni sono foriere di qualsiasi tipo di sintomi, che i medici impreparati allopati chiamano erroneamente "malattie"....

Continua da e in:    Autismo Refenze 1 + Autismo Refenze - 3 + Amish senza autismo perche' NON vaccinano

vedi anche qui:
il PDF dello studio che indica la correlazione fra Autismo e Vaccini
Metalli tossici dei vaccini = Autismo vedi: PDF -  dott. M. Proietti
vedi anche questa: raccolta di dati medico-scientifici sui gravi danni dei Vaccini

USA, Giugno 2013 - AUTISMO = 1 bambino autistico su 26, non come era nel 2010, 1 su 80
vedi QUI:

In CINA dopo le campagne vaccinali esplode l'Autismo ! - Maggio 2016
VERISSIMO, ma non solo l' una innumerevole sequela di altre malattie....

Autismo e non solo dai Vaccini:

I Tribunali anche USA, confermano tranquillamente che il vaccino MMR causa l'autismo. Austin (USA) - 27 Luglio 2013
Dopo decenni di appassionato dibattito, per i genitori che probabilmente hanno perso i ripetuti ricorsi richiesti dalle aziende farmaceutiche e governi, che i vaccini infatti causano l'autismo.
Per i genitori interessati alla ricerca della verità, vale la pena ricordare che le stesse persone che possiedono le aziende farmaceutiche di tutto il mondo possono anche possedere agenzie di stampa americane.
La Ricerca di informazioni prive di propaganda è stata fino ad ora molto difficile.
Ma Whiteout Press non è qui per sostenere o contrastare i vaccini. Siamo qui per portare i lettori la notizia che è il tema e’ in black-out, cover-up e censurato dalle autorita’Sanitarie e Governative.
Tratto da:

Gli esperti di vaccini del CDC, hanno spesso conflitti di interesse - 18/03/2010
CDC e Conflitti di interesse - 1 + CDC e Conflitti di interesse - 2 + CDC e Conflitti di interesse - 3 + Corruzione + Danni dei Vaccini + Contro Immunizzazione

CDC conflitti di interesse anche per i vaccini + anche per la FDA

La prova della FRODE del CDC per le cause dei Vaccini nell'Autismo - CONFESSIONE di un alto dirigente CDC, davanti al Congresso US

Davvero inquietante !
Questo medico il Dott. Andrew Moulden è MORTO (probabilmente assassinato) in modo inspiegabile nel novembre 2013 al età di 49, subito dopo aver pubblicato Le SUE RICERCHE che DIMOSTRANO il DANNO CAUSATO dai VACCINI, RICONOSCIBILI SOLO da un SEMPLICE ESAME ESTERNO 

Parlamentari pagati dalle Lobbies ? - Roma Ott. 2013 
L'intervista a un assistente di un Senatore che svelerebbe i traffici illeciti tra parlamentari e Lobbies.
Video dell'intervista:

Informatore dei CDC CONFESSA la FRODE e le FALSIFICAZIONI sugli studi della correlazione VACCINO=AUTISMO

Sentenza Italiana 2012 - Trib. Rimini su Vaccini=Autismo

Commento NdR: sulla sentenza di Rimini: vaccini = autismo
BENE ha fatto il Giudice del Tribunale di Rimini (Italia) a sentenziare in quel modo, perche' egli non  si e' lasciato influenzare dalle FALSITA' del Ministero della "salute" (che e' stato da noi informato sui Danni dei vaccini dal 19966 se ne sta zitto.....assieme a tutti gli altri "enti"....)  fino agli ordini dei medicii Big Pharma ! - vedi lo studio del dott.: Wakefield.htm



Vitamin A Improves Measles Complication Rates:

·        Clinical Infectious Diseases (September 1994), p. 493.

·        Oomen, APC. “Clinical experience of hypovitamine A.” Fed Proc 1958; 17:111-124.

·        Wilson, D., et al. “Infection and nutritional status. III. The effect of measles on nitrogen metabolism in children.” American Journal of Clinical Nutrition 1961; 9:154-58.

·        Sommer, A., et al. “Increased risk of respiratory disease and diarrhea in children with pre-existing mild vitamin A deficiency.” American Journal of Clinical Nutrition 1984; 40:1090-95.

·        Sommer, A., et al. “Impact of vitamin A supplementation on childhood mortality: a randomized clinical trial.” Lancet 1986; 1:1169-73.

·        “Vitamin A supplements and mortality related to measles: a randomised clinical trial.” British Medical Journal (January 31, 1987), pp. 294-96.

·        Keusch, G.T. “Vitamin A supplements—too good to be true.” New England Journal of Medicine (October 4, 1990), p. 986.

·        Frieden, T.R., et al. “Vitamin A levels and severity of measles: New York City.” Am J Dis Child 1992; 146:182-86.

·        Pediatric Nursing (September/October 1996). 

Fever Reducers (aspirin) Prolong Measles Complication Rates:

·        Witsenburg, B.C. “Measles mortality and therapy,” pp. 26-27. From an abstract of a 1967-1968 measles epidemic study conducted in Ghana.

·        Ahmady, A.S., et al. “The adverse effects of antipyretics in measles.” Indian Pediatrics (January 1981), pp. 49-52. 

The Measles (and MMR) Vaccine and Neurological Disorders (Including Central Nervous System Damage, subacute sclerosing panencephalitis [brain disease], and Guillain-Barre' syndrome [paralysis]):

·        Schneck, S.A. “Vaccination with measles and central nervous system disease.” Neurology 1968; 18 (Part 2):79-82.

·        Jabbour, J.T., et al. “Epidemiology of subacute sclerosing panencephalitis (SSPE).” Journal of the American Medical Association 1972; 220:959-62.

·        Belgamwar, R.B., et al. “Measles, mumps, rubella vaccine induced subacute sclerosing panencephalitis.” Journal of the Indian Medical Association 1997; 95(11):594.

·        Landrigan, P.J., et al. “Neurological disorders following live measles-virus vaccination.” Journal of the American Medical Association 1973; 223 (13):1459-62.

·        Miller, C.L. Lancet (September 17, 1983).

·        Beale, A.J. “Measles vaccines.” Proceedings of the Royal Society of Medicine 1974; 67:1116-1119.

·        Roden, A.T. “Fits following immunization.” Proceedings of the Royal Society of Medicine 1974; 67:24.

·        Jagdis, F., et al. “Encephalitis after administration of live measles vaccine.” Journal of the Canadian Medical Association (April 19, 1975); 112(8):972-75.

·        Hirayama, M. “Measles vaccines used in Japan.” Reviews of Infectious Diseases 1983; 5:495-503.

·        Pollock, T.M., et al. “A 7-year survey of disorders attributed to vaccination in Northwest Thames Region.” Lancet 1983; 1:753-57.

·        Jorch, G. et al. “Coincidence of virus encephalitis and measles-mumps vaccination.” Monatsschr Kinderheilkd 1984; 132(5):299-300.

·        Martinon-Torres, F., et al. “Self-limited acute encephalopathy related to measles component of viral triple vaccine.” Rev Neurol (May 1-15, 1999); 28(9):881-82.

·        Grose, C., et al. “Guillain-Barré syndrome following administration of live measles vaccine.” American Journal of Medicine 1976; 60:441-43.

·        Norrby, R. “Polyradiculitis in connection with vaccination against morbilli, parotitis and rubella.” Lakartidningen 1984; 81:1636-37.

·        Morris, K., et al. “Guillain-Barré syndrome after measles, mumps, and rubella vaccine.” Lancet 1994; 343:60. 

The Measles (and MMR) Vaccine and Serious Blood Disorders:

·        Oski, F.A. and Naiman, J.L. “Effect of live measles vaccine on the platelet count.” New England Journal of Medicine 1966; 265:352-56.

·        Bottiger, M., et al. “Swedish experience of two dose vaccination programme aiming at eliminating measles, mumps, and rubella.” British Medical Journal 1987; 295:1264-67.

·        Koch, J. et al. “Adverse events temporally associated with immunizing agents—1987 report.” Canada Diseases Weekly Report 1989; 15:151-58.

·        Fescharek, R., et al. “Measles-mumps vaccination in the FRG: an empirical analysis after 14 years of use. II. Tolerability and analysis of spontaneously reported side effects.” Vaccine 1990; 8:446-56.

·        Nieminen, U., et al. “Acute thrombocytopenic purpura following measles, mumps and rubella vaccination: A report on 23 patients.” Acta Paediatrica 1993; 82:267-70.

·        146. Farrington, P., et al. “A new method for active surveillance of adverse events from diphtheria/tetanus/pertussis and measles/mumps/rubella vaccines.” Lancet 1995; 345: 567-69.

·        Jonville-Bera, A.P., et al. “Thrombocytopenic purpura after measles, mumps, and rubella vaccination: a retrospective survey by the French Regional Pharmacovigilance Centres and Pasteur-Merieux Serums et Vaccins.” Pediatr Infect Dis J 1996; 15:44-48.

·        Beeler, J. et al. “Thrombocytopenia after immunization with measles vaccines: review of the Vaccine Adverse Events Reporting Systerm (1990-1994).” Pediatr Infect Dis J 1996; 15:88-90. 

The Measles (and MMR) Vaccine and Sensory Impairments (Including Eye Disorders and Hearing Loss):

·Kazarian, E.L., et al. “Optic neuritis complicating measles, mumps, and rubella vaccination.” American Journal of Ophthalmology 1978; 86:544-47.

·        Marshall, G.S., et al. “Diffuse retinopathy following measles, mumps, and rubella vaccination.” Pediatrics 1985; 76:989-991.

·        Brodsky, L., et al. “Sensorineural hearing loss following live measles virus vaccination.” International Journal of Pediatric Otorhinolaryngology 1985; 10:159-63.

·        Nabe-Nielsen, J., et al. “Unilateral deafness as a complication of the mumps, measles, and rubella vaccination.” British Medical Journal 1988; 297:489.

·        Hulbert, T.V., et al. “Bilateral hearing loss after measles and rubella vaccination in an adult.” New England Journal of Medicine 1991; 325:134.

·        Stewart, B.J.A., et al. “Reports of sensorineural deafness after measles, mumps, and rubella immunisation.” Archives of Diseases of Childhood 1993; 69:153-54. 

The Measles (and MMR) Vaccine and Immune System Damage (Other Than Autism):

·        Hirsch, R.L., et al. “Measles virus vaccination of measles seropositive individuals suppresses lymphocyte proliferation and chemotactic factor production.” Clinical Immunology and Immunopathology 1981; 21:341-50.

·        Nicholson, J.K.A., et al. “The effect of measles-rubella vaccination on lymphocyte populations and subpopulations in HIV-infected and healthy individuals.” Journal of Acquired Immune Deficiency Syndromes 1992; 5:528-537. 

The Measles (and MMR) Vaccine and Bowel Disease:

·        Thompson, N.P., Wakefield, A.J, et al. “Is measles vaccination a risk factor for inflammatory bowel disease?” Lancet 1995; 345:1071-1074.

·        Barton, J.R., et al. “Incidence of inflammatory bowel disease in Scottish children between 1968 and 1983: marginal fall in ulcerative colitis; three-fold rise in Crohn’s disease.” Gut 1989; 30:618-622.

·        Whelan, G. “Epidemiology of inflammatory bowel disease.” Med Clin N Am 1990; 74:1-12.

·        Ekbom, A., et al. “The role of perinatal measles infection in the aetiology of Crohn’s disease: a population-based epidemiological study.” Lancet 1994; 334:508-510.

·        Miyamoto, H., et al. “Detection of immunoreactive antigen with monoclonal antibody to measles virus in tissue from patients with Crohn’s disease.” Journal of Gastroenterology 1995; 30:28-33.

·        Wakefield, A.J., et al. “Evidence of persistent measles virus infection in Crohn’s disease.” Journal of Medical Virology 1993; 39:345-53.

·        Wakefield, A.J., et al. “Crohn’s disease: pathogenesis and persistent measles virus infection.” Gastroenterology 1995; 108:911-916.

·        Lewin, J., et al. “Confirmation of persistent measles virus infection of intestinal tissue by immunogold electron microscopy.” Gut 1995; 36:564-69. 

The Measles (and MMR) Vaccine and Severe Allergic Reactions:

·        Aukrust, L., et al. “Severe hypersensitivity or intolerance reactions to measles vaccine in six children: clinical and immunological studies.” Allergy 1980; 35(7):581-87.

·        McEwen, J. “Early-onset reaction after measles vaccination: further Australian reports.” Medical Journal of Australia 1983; 2:503-505.

·        Koch, J., et al. “Adverse events temporally associated with immunizing agents—1987 report.” Canada Diseases Weekly Report 1989; 15:151-58.

·Kelso, J.M., et al. “Anaphylaxis to measles, mumps, and rubella vaccine mediated by IgE to gelatin.” J Allergy Clin Immunol 1993; 91:867-72.

··        Sakaguchi, M., et al. “IgE antibody to gelatin in children with immediate-type reactions to measles and mumps vaccines.” J Allergy Clin Immunol 1995; 96:563-65. 

The Measles Vaccine and "Atypical" Measles:

·        Cherry, J.D. “The ‘new’ epidemiology of measles and rubella.” Hospital Practice (July 1980), pp. 53-54.

·        Fulginiti, V.A., et al. “Altered reactivity to measles virus; atypical measles in children previously immunized with inactivated measles virus vaccines.” Journal of the American Medical Association 1967; 202:1075.

·        Martin, D.B., et al. “Atypical measles in adolescents and young adults.” Annals of Internal Medicine 1979; 90:877.

·        Gold, E. “Current progress in measles eradication in the United States.” Infect Med 1997; 14(4):297-300, 310.

·        Nichols, E.M. “Atypical measles: a continuing problem.” American Journal of Public Health 1979; 69(2):160-62.

·        Scott, T.F., et al. “Reactions to live-measles-virus vaccine in children previously inoculated with killed-virus vaccine.” New England Journal of Medicine 1967; 277(5):248-251.

·        Cherry, J.D., et al. “Atypical measles in children previously immunized with attenuated measles virus vaccines.” Pediatrics 1972; 50(5).

·        St. Geme, J.W., et al. “Exaggerated natural measles following attenuated virus immunization.” Pediatrics 1976; 57:148-150.

·        “Atypical measles syndrome.” Lancet 1979, pp. 962-963. 

The Measles Death Rate Tumbled Prior to the Measles Vaccine:

·        Alderson, Michael. International Mortality Statistics (Washington, DC: Facts on File, 1981), pp. 182-183. 

The Measles Vaccine is Ineffective (Outbreaks Often Occur Among Highly, or Fully, Vaccinated Populations):

·        FDA. “FDA workshop to review warnings, use instructions, and precautionary information [on vaccines].” (Rockland, Maryland: FDA, September 18, 1992), p. 27.

·        Faich, G.A., et al. “Measles outbreak in Rhode Island.” Public Health Report 1981 May-June; 96(3):264-266.

·        CDC. MMWR (February 1, 1985).

·        CDC. MMWR (June 1984).

·        CDC. MMWR (June 6, 1987).

·        Gustafson, T. “Measles outbreak in a fully immunized secondary school population.” New England Journal of Medicine 1987; 316:771-74.

·        Markowitz, L.E., et al. “Patterns of transmission in measles outbreaks in the United States, 1985-1986.” New England Journal of Medicine 1989; 320:75-81.

·        Robertson, S.E., et al. “A million dollar measles outbreak: epidemiology, risk factors, and a selective revaccination strategy.” Public Health Reports (January-February 1992), p. 24.

·        Edmonson, M.B., et al. “Mild measles and secondary vaccine failure during a sustained outbreak in a highly vaccinated population.” Journal of the American Medical Association 1990; 263:2467-71.

·        Minnesota Department of Health. “Measles summary, 1987.”

·        CDC. “Measles.” MMWR 1989; 38:329-330.

·        CDC. “Measles—Quebec.” MMWR 1989; 38:329-30.

·        CDC. “Measles—United States, 1990. MMWR 1991; 40(2):369.

·        CDC. “U.S. Childhood Immunization Update: Measles.” (March 1997).

·        CDC. “Measles—United States, 1999.” MMWR 2000; 49(25): 557-560. 

Natural Immunity is Superior:

·        CDC. “Babies of vaccinated moms more susceptible to measles.” Pediatrics (November 1999).

·        “Natural immunity to measles yields greater neutralizing capacity than vaccination.” Journal of Medical Virology 2000; 62:91-98. 

The Measles Vaccine Alters the Epidemiology of the Disease (It Causes Higher Rates of Measles in High-Risk Groups):

·        Cherry, J.D. “The ‘new’ epidemiology of measles and rubella.” Hospital Practice (July 1980), p. 51.

·        Macgregor, J.D., et al. “Epidemic measles in Shetland during 1977 and 1978.” British Medical Journal 1981; 282(6262):434-436.

·        Gold, E. “Current progress in measles eradication in the United States.” Infect Med 1997; 14(4):297-300, 310.

·        MMWR 2000; 49(25): 557-560. 

Authorities Experimented on Children with a Proven Deadly Measles Vaccine:

·        Sabin, A.B., et al. “Successful immunization of children with and without maternal antibody by aerosolized measles vaccine. I. Different results with undiluted human diploid cell and chick embryo fibroblast vaccines.” JAMA 1983; 249:2651-62.

··        Sabin, A.B., et al. “Successful immunization of children with and without maternal antibody by aerosolized measles vaccine. II. Vaccine comparisons and evidence for multiple antibody response. JAMA 1984; 251:2363-71.

·        Whittle, H.C., et al. “Immunisation of 4-6 month old Gambian infants with Edmonston-Zagreb measles vaccine.” Lancet 1984; ii:834-37.

·        Whittle, H., et al. “Trial of high-dose Edmonston-Zagreb measles vaccine in The Gambia: antibody response and side-effects.” Lancet 1988; ii:811-814.

·        Aaby, P., et al. “Trial of high-dose Edmonston-Zagreb measles vaccine in Guinea-Bissau: protective efficacy.” Lancet 1988; i:809-811.

·        Garenne, M., et al. “Child mortality after high-titre measles vaccines: prospective study in Senegal.” Lancet 1991; 338:903-907.

·        Whittle, H.C. “Effect of dose and strain of vaccine on success of measles vaccination of infants aged 4-5 months.” Lancet 1988; i:963-66.

·        Khanum, S., et al. “Comparison of Edmonston-Zagreb and Schwartz strains of measles vaccine given by aerosol or subcutaneous injection.” Lancet 1987; i:150-53.

·        Tidjani, O., et al. “Serological effects of Edmonston-Zagreb, Schwartz, and AIK-C measles vaccine strains given at ages 4-5 or 8-10 months.” Lancet 1989; ii:1357-60.

·        Markowitz, L.E., et al. “Immunization of six-month-old infants with different doses of Edmonston-Zagreb and Schwartz measles vaccines.” New England Journal of Medicine 1990; 332:580-87.

·        Awadu, K.O. Outrage! How Babies Were Used as Guinea Pigs in an L.A. County Vaccine Experiment. (Long Beach, CA: Conscious Rastra Press, 1996).

Tratto da:

Preliminary Communication - JAMA. 2010;304(21):2389-2396. doi: 10.1001/jama.2010.1706
Cecilia Giulivi, PhD;

        Yi-Fan Zhang, BS;

        Alicja Omanska-Klusek, MS;

        Catherine Ross-Inta, BS;

        Sarah Wong, BS;

        Irva Hertz-Picciotto, PhD;

        Flora Tassonee, PhD;

        Isaac N. Pessah, PhD

Author Affiliations: Department of Molecular Biosciences, School of Veterinary Medicine (Drs Giulivi and Pessah, Mr Zhang, and Mss Omanska-Klusek, Ross-Inta, and Wong), Departments of Public Health Sciences (Dr Hertz-Picciotto) and Biochemistry and Molecular Medicine (Dr Tassone), School of Medicine (Drs Hertz-Picciotto and Tassone), and Center for Children's Environmental Health and Disease Prevention (Drs Hertz-Picciotto and Pessah), and Medical Investigations of Neurodevelopmental Disorders Institute (Drs Hertz-Picciotto, Tassone, and Pessah), University of California, Davis.

Impaired mitochondrial function may influence processes highly dependent on energy, such as neurodevelopment, and contribute to autism. No studies have evaluated mitochondrial dysfunction and mitochondrial DNA (mtDNA) abnormalities in a well-defined population of children with autism.
Objective To evaluate mitochondrial defects in children with autism.
Design, Setting, and Patients Observational study using data collected from patients aged 2 to 5 years who were a subset of children participating in the Childhood Autism Risk From Genes and Environment study in California, which is a population-based, case-control investigation with confirmed autism cases and age-matched, genetically unrelated, typically developing controls, that was launched in 2003 and is still ongoing. Mitochondrial dysfunction and mtDNA abnormalities were evaluated in lymphocytes from 10 children with autism and 10 controls.
Main Outcome Measures Oxidative phosphorylation capacity, mtDNA copy number and deletions, mitochondrial rate of hydrogen peroxide production, and plasma lactate and pyruvate.
Results The reduced nicotinamide adenine dinucleotide (NADH) oxidase activity (normalized to citrate synthase activity) in lymphocytic mitochondria from children with autism was significantly lower compared with controls (mean, 4.4 [95% confidence interval {CI}, 2.8-6.0] vs 12 [95% CI, 8-16], respectively; P = .001). The majority of children with autism (6 of 10) had complex I activity below control range values. Higher plasma pyruvate levels were found in children with autism compared with controls (0.23 mM [95% CI, 0.15-0.31 mM] vs 0.08 mM [95% CI, 0.04-0.12 mM], respectively; P = .02). Eight of 10 cases had higher pyruvate levels but only 2 cases had higher lactate levels compared with controls.
These results were consistent with the lower pyruvate dehydrogenase activity observed in children with autism compared with controls (1.0 [95% CI, 0.6-1.4] nmol × [min × mg protein]
−1 vs 2.3 [95% CI, 1.7-2.9] nmol × [min × mg protein]−1, respectively; P = .01). Children with autism had higher mitochondrial rates of hydrogen peroxide production compared with controls (0.34 [95% CI, 0.26-0.42] nmol × [min × mg of protein]−1 vs 0.16 [95% CI, 0.12-0.20] nmol × [min × mg protein]−1 by complex III; P = .02). Mitochondrial DNA overreplication was found in 5 cases (mean ratio of mtDNA to nuclear DNA: 239 [95% CI, 217-239] vs 179 [95% CI, 165-193] in controls; P = 10−4). Deletions at the segment of cytochrome b were observed in 2 cases (ratio of cytochrome b to ND1: 0.80 [95% CI, 0.68-0.92] vs 0.99 [95% CI, 0.93-1.05] for controls; P = .01).
Conclusion In this exploratory study, children with autism were more likely to have mitochondrial dysfunction, mtDNA overreplication, and mtDNA deletions than typically developing children.
Tratto da:

Autism - 10
Altra Bilbiografia:
Allerdist H, "Complicazioni neurologiche a seguito di vaccinazioni di morbillo", Dev Biol Stand, 1979; 43:259-64
Antony SJ, Fleming DF, Bradley TK, "Encefalopatia disseminata (sindrome Brown-Sequard) post vaccino influenzale", J Natl Med Assoc., sett. 1995; 87(9):705-8

Askanas A, "Encefalite post-vaccinica ed infezione da enterovirus", Pediatr Pol, feb. 1966

Auden GA, "Alterazioni nel comportamento intervenute a seguito di encefalite in bambini", The Lancet 28 ott. 1922, p.901- 904

Backman Z, "Correlazione tra disabilità mentali, manifestazioni del comportamento e tossicità ed allergia cerebrale", The Digest of Chiropractic Economics, maggio- giugno 1985, p18-19

Bakwin H, "Danno cerebrale e disutrbi del comportamento in bambini", J. Pediatrics 34 (1949) 371-382

Barbor PR, Grant DB,  "Encefalite a seguito di vaccinazione per il morbillo", The Lancet, 5 luglio 1969; 2 (7610): 55-6

Baylet RJ, Camain R,  "Encefalite post-vaccinica: uno studio virologico", Bull Soc Med Afr Noire Lang Fr, 1966;11(1):83-92

Begg NT, Noah ND, "Vaccinazioni per morbillo parotite e rosolia ed encefalite", British Med. Journal, 14 ott. 1989;  299 (6705): 978

Bender L, "Encefalopatie in bambini", Arch Pediatrics 60 (1943), p75-877
Bitnun A, "Encefalite causata dal ceppo vaccinale del virus del morbillo", Clin Infect Dis., ott. 1999; 29(4):855-61

È riportato il caso di una encefalite da virus del morbillo in un bambino apparentemente sano di 21 mesi, a distanza di 8 mesi dalla vaccinazione morbillo parotite rosolia.

Bond ED, Appel KE, "Il trattamento dei disturbi comportamentali derivanti da encefalite", New York: The Commonwealth Fund, 1931

Bond ED, Partridge GE, "Disturbi comportamentali post-encefalitici in ragazzi e loro gestione in un ospedale", Am. J. Psychiatry VI (1926/ 1927), p25-80

Bond ED, Smith LH, "Disordini comportamentali post-encefalitici: rassegna di 10 anni alla Franklin School", Am. J. Psychiatry, (1935), 92: 1, p17-33

Braginskaia VP, Sokolova AF, Ladodo KS, "Encefalite post-vaccinica in un bambino di 3 anni e 4 mesi", Vopr Okhr Materin Det., apr. 1968; 13(4):75-7

Brezin A, Lautier-Frau M, Hamedani M, "Perdita di visione ed eosinofilia a seguito di vaccino antiepatite B", The Lancet 1993; 342: 563-4

Buchner H, Ferbert A, Hundgen R, "Polineurite craniale? Encefalite e mielite del cervelletto a seguito di vaccinazione influenzale preventiva", Nervenarzt., nov. 1988; 59(11):679-82

Buchwald G, Steben B,  "Encefalite ed encefalopatia post-vaccinica", Med Welt, 22 ott. 1971

Byers, Randolph K, Moll FC, "Encefalopatie a seguito della vaccinazione profilattica di pertosse", Pediatrics 1:4 (1948), 439-457

Campbell AG, "Vaccinazione morbillo, parotite e rosolia ed encefalite", Brit Med. J., 7 ott. 1989; 299(6704): 916

Cavanagh, Brett EM, Marshall WC, Wilson J, "Il possibile ruolo adiuvante della pertosse bordetella e del vaccino della pertosse nel causare una grave sindrome encefalopatica: presentazione di 3 casi clinici", Neuropediatrics 12: 374-381 (1981)

Cho CT, "Panencefalite a seguito di vaccinazione per morbillo", JAMA, 28 maggio 1973; 224 (9): 1299

Cherry JD, Brunell PA, Golden GS, Karzon DT, "Rapporto su rassegna su pertosse e vaccinazione da pertosse", Pediatrics 81:6 Part 11 (giugno 1988) Supplement pp 936-984.

citazione:     Per più di 25 anni è stato ben noto che il vaccino della pertosse è un affidabile adiuvante per la produzione di encefalite allergica sperimentale. Questa encefalomielite allergica sperimentale è mediata da linfociti sensibilizzati piuttosto che da meccanismi di anticorpi del sangue. Il vaccino della pertosse è stato anche usato come adiuvante per ottenere le seguenti patologie autoimmuni sperimentali: tiroidite, miocardite, glomerulonefrite, uveoretinite ed anemia emolitica.

Collomb H, Dumas M, Giordano C,  "Encefalite post-vaccinica (da vaccino della febbre gialla): uno studio neuroradiologico", Bull Soc Med Afr Noire Lang Fr. 1966;11(3):587-90 
Collomb H, Rey M,  Dumas M,  "Sindromi neuropsichiche durante encefaliti post-vacciniche", Bull Soc Med Afr Noire Lang Fr., 1966; 11(3): 575-86       

Coulter H, Barbara F, "A shot in the dark", New York: Harcourt Brace Jovanovich, 1985, Ed,. Verlag 1991

Crowley S, al-Jawad ST, Kovar IZ, "Vaccinazione morbillo parotite rosolia ed encefalite", Br. Med. J., 9 sett. 1989; 299 (6700): 660

Damasio AR, Maurer RG, "Un modello neurologico per l'autismo infantile", Archives of Neurology, v.35, 1978, p. 777-86

DeLong GR, Bean SC, Brown FR, "Reversibile sindrome autistica acquisita in encefalopatia acuta in bambini", Arch. Neurology 38 (1981), 191-194

Dietrech RB, Bradley WG, Zaragoza EJ, Otto RJ, Taira RK, "Valutazione con RM della modalità di mielinizzazione in infanti normali e ritardati nello sviluppo", AJR 150 (aprile 1988), 889-896

Dietzsch HJ, "Encefalite a seguito della prima vaccinazione di varicella nonostante pretrattamento con antigeni di vaccino", Kinderarztl Prax., sett. 1966; 34(9):425-8   
Dodson WE, "Encefalopatie metaboliche nella patofisiologia neurologica", in: Eliason SG, Hardin WB, "Neurological pathophysiology", Ed. 1978, New York, Oxford

Dzagurov SG, Gurvich EB, Ozeretskovskii NA, "Risultati di uno studio della patogenesi dell'encefalite post-vaccinica: 39 casi", Vopr Virusol, luglio- agosto 1981; (4): 398-404

Ehrengut W, "Vaccinazioni di varicella con encefalite infantile post-vaccinica", JAMA, 27 agosto 1973; 225 (9):1123

Ehrengut W. "Diabete mellito da encefalite post-vaccinica", Dtsch Med Wochenschr., 15 maggio 1970; 95(20):1135

"Encefalite virale fatale a seguito di inoculazione di vaccino della febbre gialla ceppo 17D. Rapporto di un caso di un bambino di 3 anni",  JAMA, 7 nov. 1966; 198(6):671-2

Fejerman N, "Encefalite post-vaccinica", Arch Argent Pediatr, ott.- dic. 1964

Fejn DB, Skoff, mirsky AF, "Riscontri clinici di disfunzioni del cervelletto in bambini autistici", J. Autism 11:3 (1981), 303-315

Froissart M, Mizon JP, Leroux JL, "Acuta meningoencefalite immediatamente dopo una vaccinazione influenzale", Lille Med., ott. 1978; 23(8):548-51  

Fujinami RS, Oldstone MB, "Omologia di amino acidi tra il sito encefalitogenico delle proteine di base della mielina e il virus. Meccanismo per l'autoimmunità", Science 1985, 230: 1043-45

Garcia-Monco JC, Coleman JL, Benach JL, "Anticorpi alla proteina di base della mielina nel morbo di Lyme", J. of Inf. Dis. 1988; 158: 667-668

Gillberg C, "Sono l'autismo e l'anoressia nervosa correlati?", B. J. Psychiatry 143 (april 1983), 428 (a)

Gillberg C, "Epilessia manifestatasi come autismo infantile? Due casi clinici", Neuropediatrics 14 (1983), 206-212

Globus JH, Kohn JL, "Encefalopatia a seguito di vaccinazione di pertosse", J. Amer. Med. Assoc. 141:8 (1949), 507-509

Goodwin, Cowan MA, "Malassorbimento e disfunzione cerebrale: uno studio su bambini autistici", J. Autism 1 (1971), 48-62

Greenebaum JV, Leichentritt B, Rosenthal FM, "Effetti di encefaliti insorte durante l'infanzia   su comportamento e personalità: uno studio di 50 casi", Ohio Stata M. J., (1945) 4, 1018-1021

Gross WL, "Sindrome da meningoencefalite a seguito della vaccinazione influenzale", J. Neurol., 14 feb. 1978; 217(3):219-22

Gurvich EB, "Isolazione del virus vaccinia da bambini con encefalite post-vaccinica a vari intervalli dopo la vaccinazione", Acta Virol., gen. 1975; 19(1):92

Gurvich EB, "Virus vaccinia in encefalite post-vaccinica", Acta Virol., marzo 1983; 27(2):154-9

Vengono descritti 84 casi di bambini con complicazioni neurologiche a seguito di vaccinazione di varicella.

Harold E, Buttram MD, "Vaccino MPR (morbillo parotite rosolia) come potenziale causa di encefalite (infiammazione del cervello) in bambini", Townsend Letters, dic. 1997

Harper J, Williams S, "Stress ambientali precoci ed autismo infantile", M. J. Australia, 9 marzo 1974, 341-346

Hemachudha T, Griffin DE, Giffels JJ, Johnson RT, Moser AB, Phanuphak P, "Proteine di base della mielina come encefalitogeno in encefalomieliti e polineuriti a seguito di vaccinazioni antirabbiche", New England J. Med. 316:7 (1987), 369-374

Herroelen L, de Keyser J, Ebinger G, "Demielinizzazione del sistema nervoso centrale a seguito di immunizzazione con vaccino antiepatite B", Lancet 1991; 338: 1174-75

Hetzler BE, Griffin JL, "Autismo infantile e lobo temporale del cervello", J. Autism 11:3 (1981), 317-330

Hill TR, "Il problema dei disturbi di comportamento in bambini ed epidemie di encefaliti croniche", J. Neurology and Psychopathology 9:33 (1928), 1-10

Hirtz DG, Nelson KB, Ellenberg JH, "Epilessia a seguito di vaccinazioni infantili", J. Pediatrics 102:1, gen. 1983, 14-18

Horn W, "Encefalite a seguito di vaccino di varicella", Z Arztl Fortbild (Jena), 15 nov. 1965; 59 (22): 1204-6

Iwasa S, Setsuji I, Akama K, "Rigonfiamento del cervello causato dal vaccino di pertosse su topi", Japan. J. Med. Sci. Biol. 38 (1985) 53-65

Jacob J, Mannino F, "Aumento di pressione intracraniale a seguito di vaccinazioni di difteria, tetano e pertosse", A. J. Dis. Children 133 (feb. 1979), p217-218

Jagdis F, Langston C, Gurwith M, "Encefalite a seguito di somministrazione di vaccino di morbillo", Can Med Assoc J., 19 aprile 1975; 112 (8):972-5

Jennings AD, "Analisi del virus della febbre gialla isolato da un caso fatale di encefalite umana associata a vaccino", J Infect Dis., marzo 1994; 169 (3):512-8

Jorch G, Kleine M, Erwig H, "Coincidenza di encefalite da virus e vaccinazione morbillo parotite rosolia", Monatsschr Kinderheilkd., maggio 1984;132(5):299-300

Kahn E, Louis H, "Organic Driveness: a brainstem syndrome and an experience", New England J. Med. 210: 14 (5 apr. 1934), 748-756

Kandt RS, "Esame neurologico di bambini con disabilità mentali", Pediatric Clinics of North America 31:2 (aprile 1984), 297-315

Kaplanski G, Retornaz F, Durand J, Soubeyrand J, "Demielinizzazione del sistema nervoso centrale a seguito di vaccinazione antiepatite B e aplotipo HLA", J. Neurol Neurosurg Psychiatry, 1995; 58: 758-59

Kennedy RLJ, "La prognosi di sequelae di encefaliti epidemiche in bambini", A.J. Dis. Children, 28 (1924) p158-172

Kim TM, "Encefalite da virus vaccinale del morbillo in ragazza di 9 anni: studi ultrastrutturali, immunoistochimici e di ibridazione in-situ", Mod Pathol., maggio 1992; 5 (3):348-52

Klingmuller G, "Vaccinazioni di varicella ed encefalite post-vaccinica", Med Welt., 17 luglio 1965; 29:1653-4

Komoto J, Otsuki S, "Autismo infantile e distrofia muscolare di Duchenne", J. Autism, 14:2 (1984), 191- 195

Kreiner R, "Encefalite a seguito di vaccino antirabbica", Psychiatr Neurol Med Psychol (Leipz), sett. 1971; 23 (9):532-6

Kulenkampff M, Schwartzman JS, Wilson J, "Complicazioni neurologiche del vaccino di pertosse", Arch. Disease in Childhood 49:1 (gen. 1974), 46-49

Label LS, Batts DH, "Mielite trasversa causata da vaccino contenente embrione di papera", Neurol.; 1982; 34: 426-36

Labauge R, "Encefalite post-vaccinica in adulto: un caso con rapporto clinico- anatomico", Rev Neurol (Paris). 1979;135(11):803-13

È riportato il caso di un uomo di 27 anni che presentò 10 giorni dopo una serie di vaccinazioni (7 vaccini in 2 mesi) coscienza alterata, attacchi epilettici, emiplegia destra, disfunzioni vegetative e stato meningeo.

Low NL, "Studi elettroencefalografici a seguito di vaccinazione della pertosse", J. Pediatrics 47 (1955), 35-39

Louis JJ, "Un caso di encefalite dopo vaccino della febbre gialla del ceppo 17 D", Pediatrie, ott.- nov. 1981; 36 (7):547-50

Lurie LA, Greenebaum JV, Leichentritt B, Rosenthal FM, "Studi a lungo termine su bambini con comportamento post-encefalitico", A. J. Psychiatry (1947) 104, 171-179

Mar ID, "Encefalite a seguito della vaccinazione di febbre gialla", Ann Pediatr (Paris), 2 marzo 1967; 14(3):181-91

Maurer RG, Damasio AR, "Autismo infantile dal punto di vista della neurologia", J. Autism, 12:2 (1982), 195, 566- 569

McCann BS, "Asimmetrie emisferiche e autismo infantile", J. Autism 11:4 (1981), 401-411

Meerbach W, "Encefalite a seguito di vaccinazione della varicella", Schweiz Med Wochenschr., 11 sett. 1971; 101(36):1311-5

Melchior JC, "Spasmi infantili e vaccinzioni infantili di pertosse", Arch. Dis. in Childhood 52 (1977), 3-10

Merritt HH, "Textbook of neurology", sixth Edition, Philadelphia: Lea and Febiger, 1979

Miller DL, Ross R, Alderslade R, Bellmann MH, "Vaccinazioni di pertosse e gravi acute patologie neurologiche nei bambini", British M. J. 282 (16 maggio 1981), 1595- 1599

Miller HG, Stanton JB, "Conseguenze neurologiche di vaccinazioni", Q. J. Medicine 24: 89 (1954), 1-27

Mnukhin SS, Isaev DN, "Sulla natura biochimica di alcune forme schizzoidi o di psicopatia autistica", J. Autism 5 (1975), 99-108

Murphy JV, Sarff KM, Marquardt KM, "Attacchi epilettici ericorrenti a seguito di vaccinazione di difteria, tetano e pertosse", A. J. Dis. Children 138 (ott. 1984), 908-911

Naumova RP, "Encefalite insorta a seguito di vaccinazione senza reazione locale della pelle", Vrach Delo, luglio 1979, (7):114-115

Nalin DR, "Vaccinazioni di morbillo, parotite e rosolia ed encefaliti", Br. Med. J., 11 nov. 1989; 299 (6709):1219

Neal J, "Encephalitis: a clinical study", New York: Grune and Stratton, 1942    & Neal J, "Tipi di encefaliti epidemiche: un confronto dei casi visti al St. Louis nel 1933 e quelli visti a New York", Am. J. Public Health (1933), 23, p1144-1154

Osvath P, "Livelli IgE di infanti con complicazioni a seguito del vaccino della pertosse", Allergol Immunopathol (Madr), marzo-apr. 1979; 7(2): 111-4

I livelli IgE di 31 infanti che ebbero gravi complicazioni a seguito di vaccinazione di pertosse sono stati determinati attraverso RIST. I pazienti ebbero convulsioni, encefalite o sintomi di shock anafilattico. 29 su 31 avevano elevati livelli IgE. Il vaccino della pertosse è già noto provocare alterati stati di produzione Ige in roditori di laboratorio.

Palmar I, "Encefalopatia a seguito di vaccinazione per la varicella", Vojnosanit Pregl., maggio 1972; 29(5):242-4  
Pollock TM, "Sicurezza del vaccino della pertosse", Lancet, 1 ott. 1983; 2(8353):795-6

L’incidenza di bambini con anafilassi o collasso entro 24 ore dalla vaccinazione DPT è di 6 su 100.000. Vengono riportati 8 di questi casi.

Poser CM, "Encefalite post-vaccinica", Ann. Neurology 1983; 13: 341-2

Prensky AL, "Il tempo: una quarta dimensione per le encefalopatie", New England J. Med. 310:23 (1984), 1527-1528

Quitkin F, Klein Df, "Due sindromi comportamentali in giovani correlate a possibile danno cerebrale minimo", J. Psychiatryc Research 7 (1969), 131-142

Rafalowska J, "Caso di encefalite necroticans acuta nel corso di una reazione post-vaccinica", Neuropatol Pol, ott.- dic. 1965

Ravkina LI, "Encefalopatia post-vaccinica", Zh Nevropatol Psikhiatr Im S S Korsakova, 1973; 73 (2): 191-4

Ribera EF, Dutka AJ, "Polineuropatia associata con la somministrazione del vaccino antiepatite B", N. Eng. J. Med., 1983, 309: 614-15

Rivers JM, Schwentker, "Encefalomielite accompagnata da distruzione di mielite prodotta sperimentalmente in scimmie", J. Exp. Med., 1935; 61: 689-702

Romanov VA, Bereshkova RV, "Studi patomorfologici ed immunofluorescenti del neotropismo da vaccino della varicella", Zh Mikrobiol Epidemiol Immunobiol, giugno 1975; (6):66-72

Iniezione di vaccino della varicella nella circolazione di maialini di Guinea era accompagnata da sviluppo nel sistema nervoso di disturbi circolatori sub-clinici e di fenomeni distrofici infiammatori di carattere reversibile. Usando un metodo di immunofluorescenza gli antigeni del virus del vaccino è stato rivelato  nei neuroni del cervello e del fluido spinale degli animali. Notevoli processi emodinamici e processi distrofici infiammatori furono rivelati nel sistema nervoso di un bambino che era morto di encefalite post-vaccinica; antigeni al virus della varicella furono trovati in varie parti del sistema nervoso.

Rosenberg G, "Meningoencefalite a seguito del vaccino influenzale", New England J. Med. 283 (1970), 12091211

Saito H, "Encefalomielite disseminata acuta a seguito di vaccinazione influenzale", Arch Neurol., sett. 1980; 37(9): 564-6

Un 12enne, precedentemente sano, mostrò i tipici segni di encefalomielite disseminata acuta 4 giorni dopo la vaccinazione influenzale. La tomografia computerizzata dimostrò un’area sub-corticale di bassa intensità nell’emisfero cerebrale sinistro. Il fluido cerebrospinale conteneva elevati livelli di immunoglobuline, specialmente IgG, ed un rapporto anomalo della catena kappa:lambda. Test cutanei per ipersensibilità alla proteina dell’uovo furono negativi, ma fu osservato un nuovo aumento di immunoglobuline e proteine del fluido cerebrospinale entro 10 giorni dai test cutanei.

Salwa S, "Encefalite a seguito di vaccinazioni di varicella", Wiad Lek., 1 feb. 1973; 26(3):215-9

Satz P, Soper DL, Orsini DL, Henry RR, Zvi JC, "Mancinismo nell'autismo", Psychiatric Annals 15: 7 (luglio 1985), 447-449

Schain RJ, Yannet H, "Autismo infantile: un'analisi di 50 casi e considerazioni su alcuni rilevanti concetti neurologici", J. Pediatrics 57: 4 (1960), 560-567

serafetinides EA, "Epilessia, dominanza cerebrale e comportamento", in: M. Girgis & L.G. Kiloh ed., Limbic epilepsy and the dyscontrol syndrome. Amsterdam: Elsevier/ North Holland Biomedical Press, 1980

Schmutzhard E, Pohl P, Stanek G, "Anticorpi Borrelia Burgdorferi in pazienti con forma ad intermittenza di sclerosi multipla cronica progressiva", J. Neurol Neurosurg Psychiatry, 1988; 5: 1215-1218

Schoub BD, "Encefalite in un ragazzo di 13 anni a seguito di vaccino di febbre gialla del ceppo 17D", J. Infect., luglio 1990; 21(1):105-6

Schwebke D, "Osservazioni cliniche e di EEG in encefailte post-vaccinica con risultato fatale", Kinderarztl Prax., luglio 1974; 42(7):307-12

Sen Gupta PN, "Encefalite post-vaccinica: rapporto di un caso", Indian J Pediatr., dic. 1975; 42(335): 356-7

Shaw CM, Alvord FC, "Relazione mezzo di sospensione - antigene nella produzione di encefalomielite sperimentale allergica in maialini della Guinea", J. Exp. Med. 1935; 61: 689-702

Shaw FE, Graham DJ, Guess HA, "Controllo post-marketing degli eventi avversi neurologici riportati a seguito di vaccino antiepatite B. Esperienza dei primi 3 anni", Am J. Epidimiol, 1988, 127: 337:52

Stuart G, Krikorian KS, "Incidenti neuroparalitici del trattamento antirabbica", Ann. Trop. Med. 1928; 23: 327-377

Swamy H, Anisya V, Nandi SS, Kaliaperumd VG, "Complicazioni neurologiche dovute a vaccino antirabbica di tipo semplice. Aspetti clinici e terapeutici", J. Assoc. Physicians India, 1991; 39: 667- 669

Steinman L, Sriram S, Adelman NE, Zamvil S, McDevitt HO, Urich H, "Modello con murine per l'encefalopatia da vaccino della pertosse", Nature 299, 21 ott. 1982, 738-740

Stubbs EG, Crawford ML, Burger Dr, Vandenbark AA, "Depressione della risposta linfocitaria in bambini autistici", J. Autism 7 (1977), 49- 55

Student M, Sohmer H, "Riscontri dalle risposte evocate da nervi auditivi e cervelletto di lesioni organiche del cervello in bambini con tratti autistici", J. Autism 8 (1978), 13- 20

Tanguay PE, Edwards RM, "Studi elettrofisici dell'autismo: il soffio del crollo", J. Autism 12:2 (1982), 177-184

Tourbah A, Gout O, Liblau R, Cabanis EA, “Encefalite a seguito di epatite B: encefalite disseminata ricorrente o sclerosi multipla?”, Neurology, 22 luglio 1999; 53 (2):396-40

Sono valutati 8 pazienti con infiammazione del sistema nervoso centrale sviluppata entro 10 giorni settimane dalla vaccinazione dell’epatite B.

Trajkov N, "Encefalite a seguito di vaccino della varicella", God Zb Med Fak Skopje., 1971; 17:469-75

Trevisani F, Gattinara GC, Caraceni P, "Mielite trasversa a seguito di vaccini antiepatite B", J. Hepatol, 1993; 19: 317-18

Tjakradinata D, "Encefalite post-vaccinica", Paediatr Indones., nov.-dic. 1977; 17 (11-12):385-93

Vilesova IS, "Cambiamenti della proprietà del virus vaccinia isolato in encefalite post-vaccinica", Vopr Virusol., luglio-agosto 1985; 30(4):477-82
Vich V, "Contributo al problema di edema cerebrale allergico, a seguito di vaccinazione di varicella, che imita encefalite post-vaccinica", Z Arztl Fortbild (Jena), 1 nov. 1968; 62 (21):1183-5

Wainsbren BA, Cashman N, Schell RF, Johnson R, "Anticorpi Borrelia burgdorferi e sclerosi laterale amiotrofica", The Lancet, 1987; 2: 332-3
Wainsbren BA, "L'altra faccia della medaglia", Inf. Dis. News, 1992; 5:2

Walker AM, KnJick H, Thompson RS, "Eventi neurologici a seguito di vaccinazione difteria tetano pertosse", Pediatrics 81:3 (marzo 1988), 345- 349

Warren WR, "Encefalopatia dovuta al vaccino influenzale", AMA Archives Int. Med. 97 (1956), 803- 805

Watson JG, "Un bambino di 3 anni che ha sviluppato una reazione encefalitica al vaccino MPR (morbillo, parotite, rosolia) all'età di 15 mesi", Int J Pediatr Otorhinolaryngol., giugno 1990; 19 (2):189-90

Westall FC, Root-Bernstein RS, "Una spiegazione della prevenzione e della soppressione di encefalomieliti allergiche sperimentali", Mol. Immunol 1983; 2: 169-177

White F, "Vaccino del morbillo associato con encefalite in Canada", Lancet, 17 sett. 1983; 2(8351): 683-4

Wiersbitzky S, "Encefalite, meningite serosa e parotite a seguito di vaccinazione preventiva MPR?", Kinderarztl Prax., ott. 1992; 60(7):203-5

Wiersbitzky S, "Encefalite a seguito di contemporanea vaccinazione DPT, polio trivalente orale (Sabin) ed influenzale HiB", Kinderarztl Prax., giugno 1993; 61(4-5):172-3

Wiersbitzky S, "Encefalite da vaccinazione a seguito di vaccino del morbillo simile a disfunzioni ricorrenti cardiovascolari?", Kinderarztl Prax., giugno 1991; 59(6):187-8

Wiersbitzky S, "Attacchi cerebrali e encefalite a seguito di vaccini MPR, polio orale, influenzale HiB o DPT", Kinderarztl Prax., agosto 1993; 61(6):232-4

Woods CA, "Encefalopatia dovuta al vaccino influenzale", J. Pediatrics 65 (1964), 745- 748

Yates A, "Autismo: le evidenze di danno dell'emisfero sinistro", Arizona Medicine 16 (1984), 395-397


Autism: A Unique Type of Mercury Poisoning Sallie, Bernard*, Albert Enayati, B.S., Ch.E., M.S.M.E.**, Teresa Binstock, Heidi Roger, Lyn Redwood, R.N., M.S.N., C.R.N.P., Woody McGinnis, M.D.
So What's Not to Like About Andrew Wakefield ?
Secrets and lies: Is the astonishing rise in autism a medical mystery or a pharmaceutical shame? 
By Lesli Mitchell
Childhood jab linked to rise in cases of autism (Daily Express May 23, 2000) Ted Koren, D. C.
Vaccines-Trigger for Autism?
Why Does The MMR Vaccine Need To Be Suspended ?
Autism : Is there a vaccine connection?  Part I. Vaccination after delivery.------ F. Edward Yazbak, MD,
Pt 2
IMMUNE RESPONSE TO BRAIN MYELIN IN AUTISTIC CHILDREN by Vijendra K. Singh, Reed P. Warren, Dennis Odell Utah State University, July 1992
Measles-Mumps-Rubella (MMR) Vaccine as a Potential Cause of Encephalitis (Brain Inflammation) in Children by Harold E. Buttram, MD Townsend Letters Dec. 1997
The Autism Explosion by Dr Rimland (with graph showing rise in autism since MMR vaccine)
Vaccinations: The Overlooked Factors
The Role of Vaccines in the Causation of Autism and Related Disorders---Paul Shattock and Dawn Savery, Autism Research Unit, University of Sunderland, Sunderland, UK.1997
Autism 99 A National Emergency
Dawbarns solicitors vaccine fact sheet also here: Society For The Autistically Handicapped
MMR Vaccinations and Interferon-Gamma possible sequelae: neurologic and/or gastrointestinal by Teresa Binstock
VACCINATION-INDUCED NEUROPATHIES Infection, Autoimmunity, and Autism by Teresa Binstock
Binstock, T. Hypothesis: Infection, antibiotics, vaccination-induced neuropathies: Mechanisms of pathogenesis in some cases of autism, ADHD, Tourette's,  OCD, and other neurological disorders.Bit.listserv.autism January 3 1997.
Complete articles at:

Continua in: Autismo Refenze 1

Hypothesis: conjugate vaccines may predispose children to autism spectrum disorders
By Richmand BJ. -

The first conjugate vaccine was approved for use in the US in 1988 to protect infants and young children against the capsular bacteria Haemophilus influenzae type b (Hib). Since its introduction in the US, this vaccine has been approved in most developed countries, including Denmark and Israel where the vaccine was added to their national vaccine programs in 1993 and 1994, respectively.
There have been marked increases in the reported prevalence of autism spectrum disorders (ASDs) among children in the US beginning with birth cohorts in the late 1980s and in Denmark and Israel starting approximately 4-5 years later.
Although these increases may partly reflect ascertainment biases, an exogenous trigger could explain a significant portion of the reported increases in ASDs.
It is hypothesized here that the introduction of the Hib conjugate vaccine in the US in 1988 and its subsequent introduction in Denmark and Israel could explain a substantial portion of the initial increases in ASDs in those countries.
The continuation of the trend toward increased rates of ASDs could be further explained by increased usage of the vaccine, a change in 1990 in the recommended age of vaccination in the US from 15 to 2 months, increased immunogenicity of the vaccine through changes in its carrier protein, and the subsequent introduction of the conjugate vaccine for Streptococcus pneumoniae
 Although conjugate vaccines have been highly effective in protecting infants and young children from the significant morbidity and mortality caused by Hib and S. pneumoniae, the potential effects of conjugate vaccines on neural development merit close examination. Conjugate vaccines fundamentally change the manner in which the immune systems of infants and young children function by deviating their immune responses to the targeted carbohydrate antigens from a state of hypo-responsiveness to a robust B2 B cell mediated response.
This period of hypo-responsiveness to carbohydrate antigens coincides with the intense myelination process in infants and young children, and conjugate vaccines may have disrupted evolutionary forces that favored early brain development over the need to protect infants and young children from capsular bacteria.
Copyright © 2011 Elsevier Ltd. All rights reserved.
Tratto da:
Med Hypotheses. 2011 Dec;77(6):940-7. Epub 2011 Oct 10.

Continua da e in:    Autismo Refenze 1 + Autismo Refenze - 3 + Amish senza autismo perche' NON vaccinano
e QUI:  

vedi: QUI, tutti gli studi, ricerche, interviste, citate nel documentario sull'autismo dai Vaccini Vaxxed

E questa è solo una piccolissima parte della Bibliografia esistente sui danni da vaccino !
+  Bibliografia  +  Bibliografia 2  +  Bibliografia 3 Bibliografia 4 + Sostanze eterologhe nei vaccini e reazioni  +  INGREDIENTI TOSSICI anche OCCULTI, di alcuni VACCINI analizzati + Contenuto nel vaccini Trivalenti (difpertal)  +  Come si producono i Vaccinii
vedi: Bibliografia Danni dei vaccini  +  Bibliografia danni 2  +  1.000 studi sui Danni dei Vaccini